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Controlling pathogenic presence in broilers has become a priority in the poultry industry
to prevent economic losses due to disease and infection, as well as the possible contamination of
chicken products. The use of antibiotics reduces the incidence of infections; however, their
removal from production initiated the search for suitable alternatives. Probiotic in-feed
supplements have been widely evaluated as alternatives. Probiotic use has improved broiler
performance, reduced pathogenic loads, and stimulated the immune system at later life stages.
However, there is still a gap in protection during the first weeks after the chick hatches. The in
ovo supplementation of probiotics has the potential of promoting early health benefits and
protect the chick against pathogens after hatch. In the present study, the in ovo inoculation of
different probiotic species was evaluated. It was determined that the inoculation of higher
concentrations of E. faecium (107 cfu/50µL) into the egg improves growth performance and
intestinal morphology compared to lower doses (105 and 106 cfu/50µL). It was also determined
that not all B. subtilis serotypes are safe for in ovo inoculation, even if recognized as safe for use
in feed, due to a high reduction in hatchability. However, certain B. subtilis are safe for in ovo
inoculation and regulate the gut microflora through modulations in coliforms and aerobic

bacteria after hatch. Lastly, the in ovo inoculation of different Lactobacillus strains does not
affect hatchability or growth performance. However, different Lactobacillus species stimulated
cytokine production even during the first week of hatch. The bursa of Fabricius morphology was
modulated through an increase in follicular area, which could possibly induce higher antibody
production against incoming pathogenic challenges. These results indicate that the in ovo
inoculation of probiotic bacteria can induce earlier benefits to broiler health through early
changes in gut microflora, as well as early stimulation in the immune system. The early
protection provided through the in ovo inoculation of probiotics combined with the protection
obtained through the administration of probiotics in feed could potentially result in overall
healthier broilers and therefore improved performance.
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CHAPTER I
INTRODUCTION
In broiler production, several factors can affect the ability of the chicken to reach its
maximum growth potential. One of these factors is the presence of large pathogenic loads,
leading to infections and disease (Ferket and Gernat, 2006; Sugiharto, 2014). The presence of
high concentrations of pathogenic bacteria in broilers may reduce the energy available for
growth due to the energy demands required by the immune system to fight against infectious
agents (Liu et al., 2015). Infections and diseases in broilers are associated with high economic
losses for the producers due to the reduction in meat yields, as well as the elevated use of
antibiotics to treat the infections (Collet, 2013; Agyare et al., 2018). Common diseases in poultry
such as coccidiosis and necrotic enteritis can cause global economic losses of approximately $23 billion per year to the broiler producers (Paiva and McElroy, 2014; Kadykalo et al., 2018).
Controlling the bacterial presence in the gut is essential not only to reduce the incidence of
disease in broilers but also to prevent the presence of pathogenic agents from reaching the
chicken end products and resulting in food-borne infections in humans. For example, chicken
products are known vectors for Salmonella, which can lead to food-born salmonellosis in
humans. This type of infection causes approximately 1.2 million illnesses and around 500 deaths
per year (Mead et al., 1999; CDC, 2020).
The search for methods to reduce pathogenic load in the chicken gut is a priority in the
poultry industry. Antibiotics were widely utilized in broiler production through inoculation into
1

the egg before hatch, and at constant subtherapeutic levels in the feed to prevent infections
(Mehdi et al., 2018). The control of bacterial loads through the use of antibiotics leads to other
benefits such as improved feed efficiency and growth performance (Deephthi-Gadde et al., 2018;
Mehdi et al., 2018). However, recent studies have demonstrated that several pathogenic strains
have developed resistance to different antibiotics, thus making the treatment against infections
more limited in animals and humans. The threat of antibiotic-resistant strains in humans has
become of great concern for the population, hence leading to an increased demand for antibioticfree products (Scanes et al., 2018). For this reason, the search for alternatives to antibiotics that
can reduce pathogenic presence has become more prominent over the past decade (Dibner and
Richards, 2005; Breslow, 2015). Alternative methods, in conjunction with clean production
practices through the grow-out procedure, as well as elevated biosecurity levels to prevent
external pathogenic contaminations, are expected to control the incidence of pathogens in
broilers.
Probiotics have been proposed as alternatives to antibiotics because of their ability to
reduce pathogens and lead to other health improvements (Kabir, 2004). Different probiotics have
been administered in broiler feed and water at different growth stages. Beneficial effects have
been observed in pathogenic bacteria reduction (Van Coillie et al., 2007; Taheri et al., 2010;
Ghareeb et al., 2012), as well as in improvement in growth parameters such as feed intake, feed
conversion ratio, and ultimately weight gain (Kabir, 2004; Mountzouris et al., 2007;
Aliakbarpour et al., 2012; Gadde et al., 2012; Bai et al., 2013). Probiotics have also been shown
to stimulate different immune parameters that contribute to the control of antigens (pathogens)
that cause infections (Kabir et al., 2004; Haghighi et al., 2006; Incharoen et al., 2019). However,
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these benefits, including the modulations of the immune system, are not seen with all probiotic
cultures evaluated, and some effects are only seen for later periods of the grow-out.
During the first three weeks after hatch, there is a gap in protection against pathogenic
infections. Chickens carry maternal antibodies that confer certain protection against a variety of
pathogens until approximately seven days after hatch (Berghman, 2016). They also possess an
efficient immune system capable of preventing or fighting infectious agents in their bodies.
However, this system does not become fully developed until 21 days after the chick has hatched
(Tanjitkar et al., 2015). Therefore, from day 7 when maternal antibodies are depleted, until day
21 when the immune system has matured, the chicken lacks the appropriate protection against
pathogenic bacteria that could cause infection and disease. Protecting during the vulnerable first
three weeks of the chick’s life is of utmost importance for their development at the later stages of
their grow-out cycle. Other studies have administered probiotics through oral gavage on the first
day of the hatch (La Ragione and Woodward, 2003). However, this method is labor-intensive
and would lack applicability in an industrial setting where thousands of chicks are manually
administered each dose. Thus, evaluating the in ovo administration of probiotics utilizing
commercial automated Inovoject® technology (Ricks et al., 1999) has gained interest. This
automated system has been used for the past 30 years to deliver vaccines into fertile eggs
(Marangon and Busani, 2006).
Therefore, the overall objective of the current research project was to 1) investigate the
early administration of probiotics before the chick has hatched, and 2) determine if probiotics
can provide early health benefits that protect the chick during the first period of the grow-out. To
achieve the overall objectives, three research trials were conducted to evaluate different probiotic
species that were administered to the developing broiler embryo through commercial automated
3

Inovoject® technology. The objective of the first trial was to evaluate the in ovo administration of
different concentrations of an Enterococcus faecium based probiotic on hatchability, live
performance parameters, as well as intestinal and immune tissue morphology. The objective of
the second project was to evaluate the in ovo administration of three different Bacillus subtilis
serotypes to determine if all Bacillus cultures are detrimental to embryo health. Since not all B.
subtilis were detrimental to the embryos, different parameters such as hatchability, growth
performance, as well as modulations in the intestinal microflora were evaluated to establish the
beneficial effects of B. subtilis as a probiotic culture. The objective of the third study was to
evaluate the in ovo administration of different Lactobacillus species and their effect on
hatchability, growth performance, and immune status of the broiler chick. Another objective was
to determine if the different Lactobacillus cultures had the ability to alleviate the symptoms of a
coccidiosis infection. In all of these studies, the different probiotic doses were delivered into the
fertile hatching eggs through the use of the commercial automated Inovoject® technology, to
determine the applicability of this method for the delivery of probiotics.
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CHAPTER II
LITERATURE REVIEW
Poultry Production
The poultry industry has drastically changed over the past 60 years. What used to be an
egg production house-held activity has become one of the largest production industries in the
world (National Chicken Council, 2020). The U.S. alone is one of the world’s largest poultry
meat producers, representing 18% of the total production (FAO, 2020). Egg production is still
one of the leading poultry products; however, meat production peaked through the years (Scanes,
2007). The increase in the production of chicken meat is mostly due to the increasing
population’s demand for an affordable protein source. The per capita consumption increased
from 9.4 kg to 39.2 kg from 1950 to 2005 (Zhuidhof et al., 2014). Compared to other proteins,
the cost of chicken meat is lower ($1.73 /lb.) compared to beef and pork prices of approximately
$5.12/lb. and $3.30/lb., respectively (USDA Economic Research Service, 2019). With the
increasing demand of poultry products, the poultry industry has been continuously evolving to
obtain production that is more efficient and results in lower chicken prices (Scanes, 2007).
Nowadays, a 42-day old broiler weight is four times higher compared to 42-day old broilers in
the 1950’s (Zhuidhof et al. 2014; Tallentire et al., 2016). The main reasons for the increased
growth include improved genetics and breeding, well established nutritional plans that are
continually being evaluated and improved, better management techniques, and disease
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prevention using vaccines and antibiotics that reduce pathogenic challenges which can depress
growth (Ferket and Gernat, 2006; Tavárez and Solis de los Santos, 2016; Ahiwe et al., 2018).
The improvements in broiler growth over the past 60 years have been driven mainly
through genetic and breeding improvements (Tavarez and de los Santos, 2016). The leading
breeder companies such as Cobb, Aviagen, and Hubbard have control of the phenotypic mass
selection that has led to the breeds commonly used today (Oldnall, 2019). Broiler nutrition is
also fundamental to achieve elevated weight in the current broiler production system. Previous
authors described nutrition as the process of providing an animal enough nutrient to obtain their
metabolic maintenance and immune function requirements while developing their genetic
potential for growth or production (Kleyn, 2013; Oldnall, 2019). Scientists are constantly in
search for the best nutrition components for each specific breed by investigating the top
ingredients, their nutritional values, and discovering the best ratios of these ingredients to
develop the most nutritionally efficient diet (Ferket and Gernat 2006). However, nutritionists are
expected to find the best ingredients and the best ratios while maintaining an economically
feasible diet that is profitable for the producers (Oldnall, 2019).
Another critical factor for improved broiler production includes the improvement in
management practices. Over the years, producers and scientists have determined the best
environmental conditions that allow chicks to utilize their energy for growth, and not for
unnecessary metabolic or maintenance requirements. These conditions include determining the
optimal temperature, ventilation, lighting, humidity, and ammonia levels in the grow-out houses
(Ferket and Gernat, 2006; Rhodes and Moyle, 2016). Management practices also include
biosecurity, which is the processes established to prevent contamination inside the facility from
outside sources, which can be carried by humans, rodents, birds, and external equipment utilized
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for litter management (Cunningham, 2012). Although biosecurity is be considered to be a good
line of defense against infectious agents, the combination with other practices such as the use of
vaccines and antibiotics allowed poultry production to thrive over the past 50 years (Marangon
and Busani, 2007; Hoelzer et al., 2018; Mehdi et al., 2018).
The use of antibiotics and vaccines became necessary to control pathogens present in the
chicken gastrointestinal tract. Due to the high stocking densities in broiler grow-out facilities,
there is a high probability for pathogens to be present in the chickens’ gut, which can result in
infection and lead to significant diseases (National Research Council, 1980). Diseases are a
primary factor for depressed growth in broilers. Immunological stress due to antigen presence
can also significantly affect feed intake and, therefore, growth (Ferket and Gernat, 2006).
Besides the effect on broiler feed intake, the presence of antigens results in the immune system
utilizing more energy to prevent the incoming threat, which inhibits the utilization of energy for
growth purposes (Liu et al., 2015). Therefore, over the past 60 years, the use of antibiotics at low
dosages in the feed has prevented pathogenic infections, which has allowed the birds to gain
weight efficiently (Mehdi et al., 2018).
Besides the use of antibiotics, vaccine application is a common practice to prevent and
control diseases in poultry (Maragngon and Busani, 2006). The effectiveness of the vaccine
depends greatly on the type of vaccine utilized (live or inactivated). Inactivated vaccines consist
of killed viruses, and live vaccines consist of non-virulent strains that do not cause disease but
have similar genetic material and will elicit an immune response by replicating within the host
(Alexander et al., 2004). Compared to inactivated vaccines, live vaccines contain a smaller
amount of the antigen and are less susceptible to factors such as heat. Live vaccines have a
relatively lower cost compared to inactivated vaccines, and they can be easily administrated
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through drinking water. Live vaccine boost in immunity is faster and depends on bacterial/viral
cell multiplication for prolonged effects (Maragngon and Busani, 2006). Inactivated vaccines are
not capable of multiplying; therefore they are injected directly into the host. Inactivated vaccines
can therefore elicit a high level of immunity. Both types of vaccines have their set of advantages
and disadvantages, and their use depends on the need of the producer (Marangon and Busani,
2006).
For many years, vaccines were delivered through subcutaneous injections behind the
chicken’s neck (Ricks et al., 1999). However, the methods for vaccines delivery have greatly
improved over the years, with the use of in ovo injection (Marangon and Busani, 2006). The
Inovoject® machine automatically delivers the vaccine dose into the egg. Approximately 25,000
to 62,000 eggs can be inoculated per hour (Williams and Zedek, 2010), thus reducing labor cost
and time significantly when compared to manual vaccination. On day 19 of incubation, the fertile
broiler embryos are in ovo inoculated to deliver the vaccine dose. Currently, the most utilized
vaccines delivered through in ovo inoculation include vaccines against Marek’s disease, New
Castle disease, infectious bronchitis, and infectious bursal disease (Ladman et al., 2002; Hoelzer
et al., 2018; Stewart-Brown, 2020). Some vaccines are also available against Clostridium
perfringens; however, their efficacy still needs to be improved (Hoelzer et al., 2018; Jang et al.,
2018; Kobierecka et al., 2016). Similarly, the in ovo inoculation of an HVT vaccine (herpesvirus
of turkey) against Marek’s disease resulted in chicks that were less prone to infection up to eight
weeks after hatch. However, protection against this virus decreases after the eight weeks, thus
increasing the susceptibility to infection (Sharma and Burmester, 1982).
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Colonization of the chicken gut
Bacterial colonization
The microflora in the intestinal tract of chickens is extremely complex and has a vital role
in animal health and production. The microflora can influence the physiology of the gut (Awad
et al., 2012), the animal’s immune status, and the uptake and utilization of available energy (Pan
and Yu, 2013; Yadav and Jha, 2019). The entire intestinal microbiota has a density of
microorganisms ranging from 107 to 1011 logs of bacteria per gram of intestinal tissue (Apajalahti
et al., 2004; Wei et al., 2013). There are an estimated 915 operational taxonomic units (OUT’s),
classified in 13 phyla, 640 different species, and 140 different genera found in the intestinal
microflora, where more than half of these species are still unknown (Wei et al., 2013; Apajalahti
et al., 2015).
Many studies have conducted a genomic evaluation of the chickens’ gut to determine the
established microbial communities through an analysis of the total bacterial DNA to identify the
prevalent phyla in the intestinal samples (Lu et al., 2003; Apajalahti et al., 2004; Torok et al.,
2008). This type of analysis is essential for the comparison of the entire microbial communities
in chickens when subjected to different factors such as changes in diets, age, production systems,
as well as the supplementation of varying feed additives (Thomas et al., 2019). They can also
identify specific operational taxonomic units to classify closely related species (Torok et al.,
2007). Although the effectiveness of these methods has been previously mentioned, one of the
limiting factors is that they detect viable and non-viable cells. In contrast, conventional
microbiological methods recover mostly live cells (Heinrich et al., 2004). In this literature
review, we will focus on the detection of bacteria relevant to the poultry industry through the use
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of conventional microbiological methods to identify specific sites of colonization in the different
segments of the gastrointestinal tract.
The crop
The crop is considered a storage site for ingested feed, and it is needed when the
proventriculus and the gizzard are full due to their limited storage capacity. Although the crop
does not have any known nutritional role, it is the first place of feed retention where the feed
acquires moisture to aid in further digestion (Svihus, 2014). The proventriculus and the gizzard
are considered the stomach-like organs in the chick. Hydrochloric acid, pepsinogen, and gastric
juices are secreted for digestion and reduce the pH in the gut to 2 (Svihus, 2011; Svihus, 2014).
In the crop there are approximately 5.6 logs of total aerobic bacteria, 4.2 logs of coliforms and 4
log of E. coli per gram of content. In the gizzard, the concentration of bacteria is lower compared
to the crop. There are around 2.5 logs of total aerobes, total coliforms and E. coli per gram of
content (Smith and Berrang, 2006). However, the predominant bacteria in the gut are different
Lactobacilli (Witzig et al., 2015), and in the gizzard, there is a broader range of bacteria such as
Lactobacilli, Enterococcus spp., Enterobacteria, as well as coliforms (Clavijo and Flórez, 2018).
After oral infection with Salmonella enterica subsp. Enteritidis, the crop was one of the preferred
sites of colonization for this bacterium (Brownell et al., 1970; Van Immerseel et al., 2002).
The duodenum
The duodenum harbors a smaller concentration of bacteria compared to the other
intestinal segment due to the short passage time and the residual presence of bile, which acidifies
the environment (Shapiro and Sarles, 1949; Duke 1989; Svihus, 2014). Previous studies have
determined that in the duodenum more than 95% of the total fat in the diet is digested (Sklan et
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al., 1975). The duodenum does harbor bacteria, and the levels of lactic acid bacteria are normally
higher than the presence of coliforms and enterococci. Within the coliforms found in the
duodenum, Escherichia coli is the most predominant in this segment (Shapiro and Sarles, 1949).
Other bacteria present in the duodenum are Streptococci and Lactobacilli and in lower
concentrations Clostridium, Propionibacterium, Bacteroides. Most of the bacteria recovered in
this section are facultatively anaerobic, with only 39% representing strict anaerobes (Salanitro et
al.,1978).
The jejunum
The jejunum is one of the longest and heaviest sections of the small intestine. Due to its
length, it has a longer feed retention time compared to the duodenum, and it digests and absorbs
major nutrients (Svihus, 2014). Fats, proteins, and starch are absorbed in the end of the jejunum,
close to the Meckel’s diverticulum (Frikha et al., 2009; Svihus et al., 2011). The jejunum has a
high percentage of Lactobacillus, E. coli, Streptococcus, and a minimal percentage of
Clostridium (less than 0.4%). In some cases, the concentration of Clostridium can be low enough
that it cannot be easily detected (Rehman et al., 2007). High concentrations of E. faecium and E.
faecalis are detected in the jejunum (Rehman et al., 2007). Most of the bacteria identified are
facultative anaerobes, with only 20% being strict anaerobes (Salanitro et al., 1978).
The ileum
The ileum has the same length, but a lower weight compared to the jejunum (Hurwitz et
al., 1980). Its time of retention is higher compared to the jejunum, where some remaining fat,
protein, and starch digestion occur (Svihus, 2014). However, the ileum is known mainly to
absorb water and minerals (Hurwitz et al., 1973; Svihus et al., 2014). The ileum has been found
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to harbor up to 108 CFU of bacteria per gram of digesta three days after hatch (Apajalahti et al.,
2015). In the ileum, similarly to the duodenum, the most prevalent bacteria are the lactic acidproducing bacteria such as Lactobacillus, as well as Enterococcus (Ranjitkar et al., 2016). Very
few bacteria belonging to the Enterobacteriaceae genera are present in this section compared to
the ceca (Adhikari and Kwon, 2017). Clostridium spp. and C. perfringens can be found at
concentrations between 6.5-7.7 logs, mostly in chicks fed a corn and soybean meal diet (Rehman
et al., 2007). Very low levels of Bifidobacterium are detected in the ileum. E. coli concentrations
are almost as high as Lactobacillus, with more than 5 logs present (Rehman et al., 2007).
However, this is only seen during the first days of the grow-out as Clostridia presence increases
up to 11% after 15 days of the hatch (Ranjitkar et al., 2015).
The ceca
The cecum have the longest feed retention time of any of the gastrointestinal sections,
and they is responsible for water and sodium absorption (Svihus, 2014). The digested feed
contents are also fermented in the ceca to produce volatile fatty acids through anaerobic
fermentation, which slightly reduces the pH to 6.5 (Jamroz et al., 2002; Svihus et al., 2012). The
occurring fermentation is believed to be of microbial nature. Due to the anaerobic environment
in the ceca, most of the bacteria recovered are strict anaerobes (Salanitro et al., 1978). The ceca
microflora is very diverse, and over 2500 operational taxonomic units are predicted to be present
in this segment (Danzeisen et al., 2011; Yeoman et al., 2012). The ceca can harbor up to 108 to
1010 CFU of bacteria per gram of tissue three days after hatch. Throughout the lifespan of the
chicken, the ceca harbor the highest concentration of bacteria, which ranges from1010 to 1011
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CFU of bacteria per gram of tissue. Bacteria such as Streptococcus faecalis are present in large
numbers in the ceca (Shapiro and Sarles, 1949).
More specifically, the ceca harbor approximately 9 logs of Bifidobacterium, 8.9 logs of
Lactobacillus, 9.8 logs of E. coli, and 9.88 logs of Clostridium perfringens (Biggs and Parsons,
2008). Different Lactobacillus strains can also colonize each segment differently. For example,
Lactobacillus salivarius is present in the ceca compared to the ileum, while Lactobacillus
crispatus are found in the ileum at a higher concentration than in the ceca (Adhikari and Kwon,
2017). The Enterococcus and the Enterobacteriaceae genera are also present in the cecal
microbial population (Salanitro et al., 1978). Some of the primary pathogens of concern in
human health related to food-borne illness from chicken consumption are Campylobacter
jejunum and Salmonella, which can be isolated from the ceca (Hermans et al., 2011).
Campylobacter is a pathogen that can live asymptomatically in the chicken by colonizing the
ceca at concentrations as high as 106 to 108 CFU per gram (Hermans et al., 2011; Humphrey et
al., 2014). Salmonella can be found in the ceca in concentrations as high as 108 CFU per gram
(Dunkley et al., 2009). After oral infection with Salmonella enterica subsp. Enteritidis, the
cecum was one of the preferred sites of colonization for this bacterium (Brownell et al., 1970;
Van Immerseel et al., 2002).
Coccidiosis a predisposing factor for bacterial infection
It is clear that the microbiome harbors high concentrations of beneficial and nonbeneficial bacteria. Elevated levels of these bacteria, in combination with predisposing factors,
can severely affect the chicken’s health. Agents such as parasites can also colonize the intestinal
tract of the chicken. One of the most common parasites are the different Eimeria species that can
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lead to coccidiosis (Edgar, 2007). These parasites are ubiquitous in poultry environments;
however, they are mostly present at subclinical levels presenting no damage to the intestines or
infection in the host (20% prevalence) (Kadykalo et al., 2018). Clinical coccidiosis is prevalent
at 5%, presenting high lesion presence that leads to diarrhea, decreased growth, and increased
mortality (Kadykalo et al., 2019). Coccidia may be present at different stages, as oocysts within
the chicken body, which is then excreted in the feces. The oocysts sporulate in the environment
(litter), and infect other chickens (Edgar, 2007). The most common species of Eimeria colonize a
different section of the intestine and present different types of lesions. Eimeria acervulina tends
to develop in the chicken’s duodenum and show red spots as initial lesions. It is one of the most
common causes of coccidial infection, and it can be detected through white patchy lesions in the
duodenum and jejunum (Edgar, 2007; Gerhold, 2016). Eimeria brunetti can be detected in the
ceca as white red streaks (Edgar, 2007; Raman et al., 2011; Gerhold, 2016). Eimeria maxima can
be seen in the middle section of the small intestine, the jejunum, and ileum through red spots as
lesions and the release of orange slime mucus. Eimeria necatrix can be present in the entire small
intestine area as white spot lesions. Eimeria tenella is mostly found in the ceca with bloody
contents and a thick rough cecal wall (Raman et al., 2011).
The lesions caused by coccidiosis are an important predisposing factor to other bacterial
infection, due to the release of plasma proteins from the wound into the lumen. These proteins
become a nutrient form for other bacteria in the gut, such as Salmonella, E. coli, and Clostridium
perfringens, which are the major pathogens of concern for the poultry industry. Eimeria maxima
and Eimeria acervulina are known to be predisposing factors for necrotic enteritis caused by
Clostridium perfringens, avian colibacillosis caused by high presence of E. coli in the gut, as
well as salmonellosis (Van Immerseel et al., 2004; Kabir, 2010; Moore, 2016).
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Modulating the gut microbiota
Biological and environmental factors
The gut microbiota is a community of commensal, beneficial, and pathogenic bacteria
that inhabit the gastrointestinal tract of animals and humans (Pereira and Berry, 2017). Several
biological and environmental changes can lead to changes in the intestinal microbiota of
chickens. During lay and embryo development, bacterial infections in the hen’s oviducts, as well
as bacteria in poorly sanitized incubators and hatchers, can lead to colonization of the embryo’s
gut (Gantois et al., 2009). After hatch, some breeds have shown to be more susceptible to
colonization by specific pathogens such as C. perfringens (Jang et al., 2013). The known
susceptibility allows further genetic selection to avoid this breed and selected for more resistant
strains. Within the grow-out house, other factors such as biosecurity in poultry farms, litter type,
litter quality, and management as well as bacteria present in the feed (Torok et al., 2008; Pan and
Yu, 2013) can affect the microbiota of the birds. Reused litter has shown to reduce Salmonella
and Clostridium prevalence if an appropriate litter management technique is utilized (Wang et
al., 2016). More recently, further changes are detected according to different production systems.
Free-range and organic farms have increased concentrations of C. perfringens and
Bifidobacterium in the gut, most likely due to outdoor access where the chick forages and
acquires bacteria from different surfaces. The kind of feed ingredients used in this type of
production system can also influence the microbiota, as well as the reduced use of certain
antibiotics (Bjerrum et al, 2006; Gong et al, 2008). All these changes lead to differences in the
microbiome, in the immune system of the chick, and ultimately in its performance and health
status. These studies provide a guide so that preferable management programs for a particular
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production system can be arranged, which allows for the manipulation of the bird’s guts
microbiome and may reduce the risk for infection.
Dietary composition
The microbiome in the chickens gut creates a space of resources and conditions where
they can live and grow (Hutchinson, 1957). The growth, maintenance, and life of these bacteria
depend on environmental conditions, nutrient availability, and the presence of other competitors
within its niche (Pereira and Berry, 2017). The microflora that inhabits the gut utilize the
nutrients from the host diet and the nutrients produced or broken down in the gut (Pereira and
Berry, 2017). A study by Shapiro and Sarles (1949) was one of the first studies to demonstrate a
change in coliforms and lactic acid bacteria in the ceca after feed inclusion, where these bacteria
increased from 3 logs to 11 logs. The nutrients coming from the feed can be highly variable
according to the diet composition, the stage of life of the bird, the amount of feed, the
digestibility of the ingredients used, and even the feed processing technique (Adedokun and
Olojede, 2019).
The chicken diet is commonly based on cereals and the addition of amino acids, minerals,
vitamins, fats, and, more recently, supplements such as enzymes, probiotics, and antibiotics
(Borda-Molina et al., 2018). Rehman et al., (2007) showed how a corn-based or wheat-based diet
influenced the microbial community in the ceca. Changes in the microflora can also been seen
according to the type of ingredient in the diet due to the change in nutritional characteristics.
Ingredients such as non-starch polysaccharides (NSP) are not easily broken down in the
chickens’ gut (Adedokun and Olojede, 2019). This can result in a high percentage of nutrients
that are not digested/absorbed, which increases lumen viscosity and feed retention time in the gut
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(Borda-Molina et al, 2018). Therefore, the use of NSP promotes an increase in the incidence of
C. perfringens compared to corn-based diets (Annett et al., 2002). The use of different protein
sources such as soybean or fishmeal has also led to microbiome modulations, including a higher
presence of food-borne pathogens such as Campylobacter in the chicken’s gut (Drew et al.,
2004; Lourenco et al., 2019). The prevalence of Campylobacter may be due to the increased
glycine and methionine level in the fishmeal diet, which becomes available for bacterial growth
and sporulation (Drew et al., 2004).
The use of antibiotics for bacterial reduction
The previously mentioned factors affecting the microbiome have been studies to
determine the effect of a pre-established condition such as housing and diet. However, a more
intentional way to regulate the chicken microbiome has been the use of antibiotics in feed or in
ovo in poultry production. Antibiotics have been widely used by the poultry industry for the past
50 years to improve performance (Gustafson and Bowen, 1997; Chattopadhyay, 2014). Different
research has investigated how antibiotics modulated bacterial presence in the gut. Low doses of
antibiotics in the fed increase the presence of bacteria that have a higher tendency to produce
short-chain fatty acids. These bacteria can therefore metabolize indigestible feed ingredient, as
well as reduce pH levels that inhibit other pathogenic bacteria that are sensitive to more acidic
conditions (Banerjee et al., 2018). The use of bacitracin in the diet also seems to reduce
Bifidobacterium and Lactobacillus concentrations (Lu et al., 2008; Díaz Carrasco et al., 2018),
while enrofloxacin and amoxicillin reduced the overall microbial diversity 6 days after its
administration when compared to a non-antibiotic diet (Wisselink et al., 2017). In another study,
amoxicillin also decreased Lactobacillus but increased Enterococcus (Schokker et al., 2017). It
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has also been shown that antibiotics may not cause a specific increase or decrease in total
bacterial numbers. However, the changes that occur alter the type of bacterial species in the
microbiome (Torok et al., 2008; Costa et al., 2017). An example of this was demonstrated when
Avilamycin was added to a diet, and E. faecium and Pediococcus acidophilus concentrations
were reduced, but Pseudomonas concentrations were increased when compared to control diets
(La-Ongkhum et al., 2011).
Antibiotics in the poultry industry
As previously mentioned, antibiotics were widely utilized in the poultry industry to
improve meat production through improved feed conversion, increased growth, and prevention
of diseases to avoid depressed growth (Engberg et al., 2000; Gadde et al., 2018). Several studies
have investigated the specific effects obtained with the use of antibiotics in the chicken’s body to
explain their ability to promote growth. Antibiotics can diminish infections by reducing bacteria
present in the body, which allows the bird to invest their energy in growth rather than fighting an
infection through an elevated immune response (Dibner and Richards, 2005; Shang et al., 2018).
The reduction of bacteria in the gut can also lead to higher nutrient availability for intestinal
absorption, given that fewer bacteria are consuming the available nutrients (Dibner and Richards,
2005; Gaskins et al., 2006; Niewold, 2007). It has been suggested that antibiotics can cause
intestinal thinning and reduce intestinal weight due to their anti-inflammatory role. These
changes are believed to reduce the use of energy for intestinal growth throughout the bird’s life,
which allows it to be utilized for growth (Niewold, 2007; Metzler-Zebeli et al., 2019).
Although the previously mentioned factors seem to play a role in broiler growth
promotion, the main functions of antibiotics are bactericidal and bacteriostatic so that pathogenic
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infections in the chicken’s body can be controlled. Their role in modulating bacterial
concentrations depends on their mechanisms of action, which in most cases, interfere with the
vital function and components of each pathogen (Kohanski et al., 2010). Antibiotics target
bacterial cell wall synthesis, protein synthesis, nucleic acid synthesis, and bacterial metabolism.
These targets are specifically chosen because they are not present in the human cell; therefore, no
harm is inflicted on cellular functions (Murray et al., 2015; Kapoor et al., 2017). Antibiotics
affecting cell wall functions include β-lactamases such as penicillin, vancomycin, bacitracin,
polymyxin, and isoniazid (Murray et al., 2015). Antibiotics affecting the protein synthesis can be
classified according to the ribosomal subunits. They affect either 30S or 60S subunits by
preventing tRNA from binding to these units or preventing the elongation of the polypeptide
chains that form each protein. In the 30S subunit, we can find tetracycline and aminoglycosides,
and in the 50S subunit, we can find chloramphenicol and macrolides such as erythromycin and
clindamycin (Murray et al., 2015; Polikanov et al., 2018). Antibiotics that inhibit DNA synthesis
include quinolones such as nalidixic acid and fluoroquinolones, such as ciprofloxacin (Murray et
al., 2015; Kapoor et al., 2017).
Antibiotics used in the poultry industry and recent concerns
In the North American poultry production industry, antibiotics commonly used include
fluoroquinolones (enrofloxacin, sarafloxacin) tetracycline, bacitracin, tylosin, salinomycin, and
virginiamycin. Tetracycline is the most used antibiotic representing a third of the total antibiotic
utilized by the poultry industry (Graham and Boland, 2007; Mehdi et al., 2018). The use of
antibiotics as growth promoters has become more limited in the U.S. due to consumer concern
about their use becoming a risk to human health. For example, for the control of Salmonella,
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different antibiotics such as fluoroquinolones, chloramphenicol, and ampicillin are utilized.
However, some Salmonella species have developed resistance to these types of antibiotics,
making infections in both the chicken and the human harder to treat (Molbac et al., 1999). It has
been proved that the use of subtherapeutic doses of antibiotics for growth promotion in poultry
can lead to bacteria acquiring resistance to antibiotics (Agyare et al., 2018). Antibiotic resistance
can be acquired by different bacteria through the intracellular inactivation of the antibiotic, by
removing the antibiotics from the cell through efflux pumps, or modifying/inactivating the
antibiotic mechanisms through methylation, phosphorylation, acetylation, or adenylation to
reduce the recognition pattern of each antibiotic (Walsh, 2003).
A previous study mentions that not all antibiotics used in animal production are utilized
to treat human infections. Therefore, resistance to antibiotics for human use should not be
common (Hughes and Heritage, 2007). However, there are still some antibiotics used in both
animals and humans, such as penicillin, macrolides, virginiamycin, streptogramin, and
chlortetracycline that allow the antibiotic resistance threat to become a real issue (Agyare et al.,
2018). Only some antibiotics such as bacitracin and other ionophores such as monesin and
naracin are exclusively utilized in animal medicine. Thus, the threat of antibiotic resistance in
bacteria has led to public concern about their use in poultry production (Scanes et al., 2018).
Several poultry producing companies and fast foods chains have eliminated their use in the U.S.
nowadays due to consumer demand for an antibiotic-free product (Dibner and Richards, 2005;
Breslow, 2015). With the reduction in antibiotic use, some pathogens, such as C. perfringens
have become more prevalent in the chicken houses (Van Immersel et al., 2004). Therefore, new
strategies to reduce the presence of pathogens in the chicken gut microbiome have become of
interest to the poultry industry.
23

Establishment of a healthy chicken microbiota
The establishment of a healthy microbiota in chickens has changed with the current
changes in production. In the initial poultry production setting, the hens would be in contact with
their eggs during the brooding period to provide warmth for proper embryonic development.
Through this process, a protective layer of microflora was provided from in the hen’s feces
(Kabir et al., 2004; Kubasova et al., 2019). Nowadays, laid eggs are collected daily and
incubated in sanitized incubators. Therefore, there is limited time for hen-egg interactions and
the layer of protection previously conferred by the hen is restricted (Kabir, 2009). After hatch,
the development of a “mature” microbiota in broilers occurs during days 15 to 22 (Ranjitkar et
al., 2015). Due to the lack of maternal protection, the chick can become vulnerable to
colonization and infection by pathogenic bacteria, especially during the first weeks after hatch
(Kabir et al., 2004;). To overcome this problem, the inoculation of day-old broilers with an adult
chicken microflora was found to reduce Salmonella and Campylobacter in the ceca (Stern et al.,
2001). Although beneficial effects are obtained, delivering the microflora culture to each chick
through oral gavage is labor-intensive and lacks applicability in industrial production systems.
As previously mentioned, for many years, antibiotics reduced pathogenic infections.
However, the removal of sub-therapeutic doses of antibiotics has resulted in higher incidences of
disease and, therefore, depressed growth and increased mortality (National Research Council,
1980). However, different claims have been made about the effects of the removal of antibiotics
on growth performance parameters (Graham et al., 2007). Nevertheless, besides the effects of the
removal of antibiotics on growth performance, the elevated presence of pathogens in the gut can
have severe implications for animal and human health (Mehdi et al., 2018). Thus, the search for
antibiotic alternatives has increased in the poultry industry over the last 20 years.
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Among the available alternatives, phytogenic feed additives derived from natural sources
such as plants, spices, trees, and herbs that possess antimicrobial activities have been
investigated. Essential oils have also been utilized, and they constitute the oily substances from
plant-based extracts, and many of them have antimicrobial activities against pathogens such as
Salmonella and Campylobacter in poultry (Mehdi et al., 2019; Micciche et al., 2019). Organic
acids have also been evaluated due to their antimicrobial properties. These compounds are weak
acids that partly dissociate at a pH between 3 to 5 and can diffuse through the bacterial
membrane and disrupt enzymatic reactions and the transport system necessary for bacterial cell
survival (Gadde et al., 2016; Khan and Iqbal, 2016; Mehdi et al., 2018). Enzymes have become
very popular due to their ability to degrade proteins and improve nutrient absorption (Gadde et
al., 2016; Mehdi et al., 2018). Another alternative available is probiotics, which have been
defined as “live micro-organisms when administered in adequate amounts; confer a health
benefit to the host” (WHO, 2001). Granted that the microbiome has such a strong influence on
chicken intestinal morphology, immune status, growth, and overall health, most of the suggested
alternatives to antibiotics have the objective of establishing a healthier microbiota (Gadde et al.,
2016). These methods are expected to reduce pathogens through their antimicrobial activities to
obtain a healthier animal, with low mortality rates, and improved growth.
The use of probiotics in broiler production
The administration of probiotics to the chickens has become a widely suggested method
to increase the presence of beneficial bacteria and obtain a healthier microbiota (Kabir et al.,
2009). As previously defined, probiotics are live microorganisms that, when consumed, can exert
beneficial effects to the host. Probiotics can contain bacterial cultures, yeast cells, or a
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combination of both (Otutumi et al., 2012). Besides their health benefits, there are other
requirements for the ideal probiotics including: originating from the host they will be applied to,
in this case of chicken origin to ensure that it will not detrimentally affect the chicken health; as
well as not presenting pathogenic characteristics (Patterson and Burkholder, 2003; Kabir et al.,
2009; Otutumi et al., 2012). Probiotic cultures should resist harsh stomach or digestive
conditions, and therefore adhere to the epithelium or mucus to persist in the gastrointestinal tract.
They should produce inhibitory compounds to reduce pathogens and exert beneficial effects on
the bird’s health. These cultures should withstand the processes to allow them to be incorporated
into the feed or water (Patterson and Burkholder, 2003; Kabir et al., 2009; Otutumi et al., 2012).
These processes involve lyophilization, microencapsulation, spray drying, or sporulation which
is exclusive for only certain types of bacterial cultures (Casula and Cutting, 2002; FAO, 2016).
According to previous studies, the most commonly used probiotic species are
Lactobacillus, Bacillus, Bifidobacterium, Enterococcus, E. coli, Lactococcus, Streptococcus,
Pediococcus species, and yeast species alone or in combination within the different bacterial
species (Patterson and Burkholder, 2003; Kabir et al., 2009; Ottumi et al., 2012; Jadhav et al.,
2015). Only some of these cultures originate from the host (chicken) intestinal contents such as
Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus helveticus, Lactobacillus lactis,
Lactobacillus salivarius, Lactobacillus plantarum, Enterococcus faecium, Enterococcus faecalis,
Bifidobacterium spp. and Escherichia coli. None of the Bacillus strains, Lactobacillus bulgaricus
and Streptococcus thermophilus are known to be ubiquitous in the gut (Patterson and
Burkholder, 2003; Hong et al., 2005; Kabir et al., 2009; Jadhav et al., 2015). However, different
species within the previously mentioned cultures have been evaluated as probiotic candidates
alone or in combination in broilers (La Ragione and Woodward, 2003; Khan et al., 2007;
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Ghareeb et al., 2012). The previously mentioned criteria that establishes that ideal probiotics
should originate from the host intestines is mainly a suggestion to avoid negative impacts
associated with contamination. However, other cultures can be used if proper evaluations are
conducted to determine if the use of these products is safe for the bird and the health benefits
they can provide (Kabir, 2009).
There are several mechanisms of action for probiotics, and they can differ according to
each bacterial species utilized. However, the most common mechanisms of action include
reducing the presence of pathogenic bacteria through the production of antimicrobial substances
and competitive exclusion or antagonism. Probiotics can also induce morphological changes that
improve nutrient absorption, digestion, and ultimately growth parameters. Probiotics can induce
immune modulations, thus activating the different levels of protection prematurely against
antigens (Patterson and Burkholder, 2003; Kabir, 2009; Otutumi et al., 2012; Al-Khalaifah,
2018). These mechanisms of action have been extensively evaluated when administering
probiotics into the chicken feed, and they will be reviewed in the next section.
The effect of probiotics on the gut microflora
The multiple mechanisms of actions of probiotics can significantly affect the microbiota
in the chicken intestinal tract. Lactobacillus species have a major advantage over other probiotics
with their ability to adhere to the intestinal epithelium and competitively exclude pathogens
(Lebeer et al., 2008). For this reason, Lactobacillus are one of the most prominent species in the
chicken intestine (Rehman et al., 2007). Previous studies have demonstrated that Lactobacillus
acidophilus and Streptococcus faecium colonizing the intestinal epithelium can reduce the
presence of Campylobacter jejuni and Salmonella enterica by reducing the sites of colonization
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for these pathogens (Morishita et al., 1997; Van Coillie et al., 2007). Enterococcus faecium,
Pediococcus acidilactici, Lactobacillus salivarius, and Lactobacillus reuteri isolated from the
chicken gut and administered in water to day-old broiler chicks showed reduced Campylobacter
jejuni at concentrations as high as four logs (Ghareeb et al., 2012). Broilers fed diets
supplemented with P. acidilacti also had lower (P < 0.05) coliforms counts in the ileum (Hamid
et al., 2010).
E. faecium as a probiotic culture is known to withstand harsh conditions such as low pH
and high temperatures. They can produce a wide range of bacteriocins to reduce pathogens in the
gut (Hanchi et al., 2018). In poultry, E. faecium based probiotic supplements added in the feed
have shown to reduce E. coli and C. perfringens concentrations on some days of the grow-out,
while increasing the concentration of beneficial bacteria such as Lactobacillus and
Bifidobacterium in the ceca (Royan, 2018; Cao et al., 2019). Salmonella populations are also
reduced with the in-feed administration of E. faecium (Capcarova et al., 2010). The application
of a probiotic E. faecium, L. sakei and B. subtilis significantly increased the lactic acid bacteria
present in the gut (Hosoi et al., 2000; Jeong and Kim, 2014; Park et al., 2016). Perhaps the ability
to reduce certain pathogens without affecting the natural beneficial microbiota, is one of the most
important characteristics of probiotics as compared to antibiotics.
Different Bacillus species are known for their ability to produce antimicrobial peptides
and enzymes that can modulate the bacteria presence in the gut. Some antimicrobial peptides
produced by Bacillus include gramicidin, tyrocidine, bacitracin, surfactin, iturins, and fengycin
(Abriouel et al., 2011; Sumi et al., 2015). As previously mentioned in the antibiotic section,
bacitracin was commonly used as an antibiotic by the poultry industry before the removal of
antibiotic from production. However, Bacillus are naturally producing lower concentrations of
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this antibiotic, which can modulate the bacteria in the gut. Sumi et al., (2015) and Abriouel et al.,
(2010) elaborated on this in an extensive review of all the antimicrobial peptides produced by
each type of Bacillus species and what pathogens they can target. When added to the poultry
feed, Bacillus can reduce S. Typhymirium and Clostridium perfringens concentrations
(Shivaramaiah et al., 2011; Sen et al., 2012; Ramlucken et al., 2020). An oral gavage dose of
Bacillus subtilis can reduce the colonization and persistence of C. perfringens and S. Enteritidis
for 36 days after ingestion (La Ragione and Woodward, 2003). This probiotic has become of
particular interest due to their ability to become spores under certain conditions. These spores
can withstand high temperatures during pelleting and other harsh environments such as the acidic
environment in the stomach (Shivaramaiah et al., 2011). Bacillus species are ubiquitous in the
environment, such as the soil, air, and water, thus they can be found at low concentrations in the
normal intestinal flora of chickens (Cartman et al., 2008; Shivaramaiah et al., 2011).
The immune system and probiotic modulations
Avian immune system and its components
Maternal antibodies are transmitted from the hen to the eggs and, ultimately, the embryo.
Maternal antibodies present in the egg yolk and plasma are consumed slowly starting on day 12,
although most of the absorption occurs around day 18-19 of incubation when the yolk is
immersed within the embryo’s abdominal cavity (Uni, 2014; Şahan et al., 2014). These
antibodies include IgG, IgA, and IgM, which are present at relatively low levels and can be
found in the blood circulating through the chick’s body mostly from day 1 to 7 after hatch (Sahin
et al., 2001). After day 7, the levels of maternal immunoglobulin drastically drop, leaving the
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chick unprotected until week three when its own immune system becomes fully developed (Seto,
1981; Berghman, 2016).
The immune system can be divided into two main categories: innate immunity and
acquired immunity. The development of innate immunity starts with the detection of foreign
agents such as pathogens, viruses, or parasites. These agents become more diverse and complex
after the chick hatches and gets in contact with re-used litter (Wang et al., 2017). Innate
immunity is the first line of defense against incoming antigens (Júnior et al., 2018). The main
components of the innate system are mucosal barriers, phagocytic cells, T cells, and natural killer
cells, as well as the complement system (Delves and Roit, 2000). The first line of defense is
provided by phagocytic cells such as heterophils, which release enzymes and peptides to
eliminate and phagocytose antigens (Alkie et al., 2019). These cells are present in the blood, and
their concentration is higher in the first days of the chick’s life. Antigens are recognized by the
innate immunity through pattern associated recognition receptors (PAMPS) located in the
cytosol and outer membrane (Schat et al., 2014). The PAMPS recognize lipopolysaccharides of
Gram-negative bacteria and peptidoglycan of Gram-negative and Gram-positive bacteria (Winn
et al., 2006), as well as other acids associated with viral identification (Dziarski, 2003). The
peptidoglycan is an essential component in the cell wall of all bacteria, and lipopolysaccharides
are an integral component of Gram-negative bacteria (Alexander and Rietschel, 2001; Dziarski,
2003). The components of both cell walls, such as oligosaccharides and lipid components,
determine the endotoxin activities and essential functions of each bacteria (Rietschel et al.,
1994).
After the first line of defense, a series of reactions occur, such as the release of cytokines,
chemokines, and other proteins that initiate inflammation and an antiviral response (Junior et al.,
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2018). The innate immune system recognizes any type of bacterial and viral presence (including
probiotic bacteria) and proceeds to initiate the adaptive immunity with the help of cytokines
through signaling cascades induced by heterophils (Alkie et al., 2019). Cytokines are proteins
released by cells to activate and regulate other cells and tissues by suppressing or developing cell
proliferation, differentiation, activation, and motility (Kogut, 2000; Wigley and Kaiser, 2003).
Several cytokines in chickens are similar to the cytokines present in humans. Nevertheless,
cytokine evaluation is complex, and it has not until recently been further explored in broiler
production. There is still a gap in knowledge to fully understand how cytokines are being
modulated by the use of probiotics.
The adaptive immune response is the second level of protection, and it is expressed after
several days, allowing a high specificity to target antigens to be acquired (Chaplin, 2010). The
adaptive immune system can be further divided into humoral immunity and cell-mediated
immunity. In chickens, the humoral immunity contains b-cells produced in the bursa and the cellmediated immunity is made up by T-cells produced in the thymus that express antigen-specific
receptors on their surface (Glick, 1986; Delves and Roitt, 2000; Erf, 2004). T-cells are
differentiated as T helper cells (CD4+T), which assist in antibody production, cytotoxic cells
(CD8+T), and natural killer cells, which destroy antigens through different methods (Erf, 2004).
B-cells are the main producers of immunoglobulins, which are also highly specific to their target
(Junior et al., 2018). The Bursa of Fabricius was studied by Glick (1956), who determined this
organ’s importance for immune system development. The bursa is arranged by several bursa
folds, which are composed of follicles. There are approximately 8,000 to 12,000 follicles that can
synthesize b-cells (Olah and Glick, 1978). Therefore, antigen detection initiates a cascade
response to produce more b-cells and thus more immunoglobulins against an antigen. The
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chicken possesses IgM, IgA, and IgY in which IgM is more prominent acting in the innate
immune system, while the latter is more active in the adaptive immune system (Junior et al.,
2018).
Immunomodulation caused by probiotic supplementation in broilers
The majority of probiotic cultures, such as Lactobacillus, Bacillus, Enterococcus,
Streptococcus, Bifidobacterium are Gram-positive bacteria characterized by peptidoglycans in
their cell wall. This characteristic initiates the stimulation of the immune system when probiotics
are administered in the chick’s feed (Dziarski, 2003). Although the chick starts developing a
microbiome when it is placed in a grow-out facility, the concentrations of bacteria are
considerably high until one week after hatch (Mead et al., 1999), and a mature microbiota is not
obtained until day 15 to 21 (Ranjitkar et al., 2016). Until these days, there is a risk for pathogenic
infections due to an immature immune system. Thus, the administration of beneficial bacteria is
advantageous for the development of the immune system and the protection against pathogenic
infections.
Haghighi et al., (2006) demonstrated that the production of IgA with specificity against
C. perfringens increased with the administration of a multi-strain probiotic culture. Overall
antibody production also increased with a multi-strain or a single strain Lactobacillus probiotic
as demonstrated by (Kabir et al., 2004; Zulkifli et al., 2000). In this same study, the increase in
antibodies was thought to be due to an increase in the weight of the spleen and bursa (Kabir et
al., 2004). In other studies, an increase in T-cell production and cytokine (IFN gamma) levels
were observed when feeding a Lactobacillus based probiotic. These modulations were found to
reduce the severity of a coccidiosis challenge (Bai et al., 2013; Dalloul et al., 2005). The
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administration of L. plantarum in feed stimulated the production of certain cytokines such as IL12 (Incharoen et al., 2019). It has also been demonstrated that pathogens such as Salmonella
when present at subclinical levels can be silently mitigating the production of immunoglobulins.
However, the administration of L. johnsonnii in feed returned immunoglobulin levels to normal
in the ileum (Wang et al., 2017). Probiotic supplementation of B. subtilis has been found to
increase IgM levels, but not IgA or IgY levels (Fathi et al., 2017). Midilli et al., (2008) detected
no regulation in IgG concentration through the administration of a commercial product
containing B. licheniformis and B. subtilis in the feed. The in-feed administration of different
probiotics seems to result in various effects in the immune system of the chicken. For this reason,
probiotics need to be further evaluated to establish which probiotic cultures are beneficial for
broiler health.
Intestinal morphology and growth performance modulations by probiotics
The previously described effects on pathogenic reduction, as well as the
immunomodulation observed through the supplementation of probiotics, are major contributing
factors affecting the chick’s growth performance. Besides the previously mentioned factors,
probiotics can also modulate the intestinal morphology to improve nutrient absorption and
improve growth parameters. Probiotics such as L. sakei modulate the intestinal morphology
through cell mitosis activation as well as the proliferation of epithelial cells in the intestine (Park
et al., 2016). This leads to higher villi length and, therefore, an increased surface area for
improved nutrient absorption. Villi height in the duodenum and ileum have also been found to
increase with the supplementation of Pediococcus acidlactici and other multi strain probiotics
(Gunal et al., 2006; Hamid et al., 2010). Bacillus based probiotics added in the feed have also
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resulted in an increase in villi height in the duodenum (Ramlucken et al., 2020). The
administration of Bacillus coagulans resulted in an increase in the villus height to crypt depth
ratio of the duodenum and jejunum (Li et al., 2019). Changes in intestinal morphology by
different probiotic species led to an increase in BW gain and a reduced feed conversion ratio
(FCR) on later stages of the grow-out (Samanya and Yamauchi, 2002; Taheri et al., 2010;
Ramlucken et al., 2020). On the other hand, Gunal et al., (2006) detected increased villus height
on one day of the grow-out with the use of probiotics but showed no improvements in growth
performance parameters. Other probiotics containing multi species; Lactobacillus acidophilus,
Lactobacillus casei, Bifidobacterium bifidum, Bacillus subtilis natto, and Enterococcus faecium
increased villi height in the jejunum but not in the duodenum and ileum (Samanya and
Yamuachy, 2002; Smirnov et al., 2005). The differences obtained in intestinal morphological
changes may be due to the specific colonization site for each probiotic bacterium within the gut
and where it exerts its beneficial effect.
Not all studies evaluating probiotics measured changes in intestinal morphology;
however, many studies evaluate the improvements in growth performance. The supplementation
of B. subtilis (Aliakbarpour et al., 2012) and Lactobacillus in broiler feed resulted in higher
body weight on the last day of a 42-day grow-out, as well as on day 1 to 14 (Gadde et al., 2012)
and day 1 to 22 (Aliakbapour et al., 2012; Bai et al., 2013; Murshed and Abudabos, 2015). A
reduction in FCR was obtained through the administration of B. subtilis in the diet due to an
increase in mucin expression in the gut, which resulted in mucosal cell proliferation and a more
efficient nutrient absorption (Aliakbapour et al., 2012; Gadde et al., 2012). The morphological
changes in the intestine, as well as the production of mucin, are thought to be responsible for the
improvements in feed conversion rate (Aliakbapour et al., 2012). Similarly, a commercial source
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of B. subtilis for in-feed supplementation reduced the FCR by 12 points compared to control
diets (Murshed and Abudabos, 2015). B. coagulans improved average body weight gain, average
daily weight gain, and reduced FCR. (Li et al., 2019).
The administration of a multi-strain probiotic culture containing L. reuteri, E. faecium, B.
animalis, P. acidilacti, and L. salivarius in broiler feed, was also observed to improve the feed
conversion ratio and weight gain as demonstrated by (Mountzouris et al., 2007). The
administration of two combined Bacillus subtilis and B. licheniformis cultures was found to
improve the FCR of broilers. However, no effects were detected for broiler body weight (Midilli
et al., 2008). E. faecium based probiotics were also shown to improve BW gain and a reduced
feed intake (Samli et al., 2007; Samli et al., 2010). However, contrary to these results, Zhao et
al., (2013) demonstrated that E. faecium caused no improvements in growth performance
parameters. The in-feed supplementation of C. butyricum resulted in increased average daily feed
intake, and daily weight gain (Zhao et al., 2013). The combination of E. faecium and L.
fermentun increased the BW gain on the last day of the grow-out (day 39) (Capcarova et al.,
2010). According to the previous studies, not all the probiotic bacteria have beneficial effects or
detrimental effects. In addition, some of the changes in performance are limited to certain days
of the grow-out. Although most changes seem to be mostly beneficial, there is still a gap in
obtaining a suitable alternative to antibiotics, which could be filled with an earlier delivery of
probiotics.
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Early establishment of a beneficial microbiota through in ovo inoculation
Early studies of competitive exclusion and probiotic culture injection
The in-feed administration of probiotics at different feeding stages showed multiple
benefits toward the improvement of broiler health, mostly at later life stages of the chicken.
However, on the earlier stages after the chick hatches and depletes the stored maternal antibodies
(Seto, 1981; Berghman, 2016), there is a gap in protection until the immune system becomes
fully developed at week three post-hatch (Ranjitkar et al., 2016). The first three weeks of life
determine how the broiler grows and reaches its maximum performance potential in later life
stages. However, this potential can be severely affected by the elevated presence of pathogens
due to infections (Juul-Madsen et al., 2004). During their first weeks after hatch, it is necessary
to confer the chick with protection against pathogens through a beneficial microbiota that can
outcompete those pathogens and cause an earlier stimulation of the immune system (earlier than
three weeks). The microbiome begins to slowly develop as the chick is placed in a grow-out
facility and is in contact with bacteria present in the litter (Wang et al., 2016). However, not only
beneficial bacteria are present in the litter, thus providing an opportunity for pathogenic
infections.
It has been thought that an earlier development of a healthy microbiota, and therefore
some immune stimulations can be obtained with a previous administration of probiotics.
Probiotics can be delivered to the embryo before the chick has hatched through in ovo
inoculation, before any contact with the environment. In the early 1990’s, Cox and colleagues
recognized that chicks were highly susceptible to Salmonella colonization due to the delay in the
establishment of the microbiota. Cox et al., (1992) studied the in ovo delivery of a competitive
exclusion into the fertile egg based on previous study by Stavric et al., (2008). In Stavric’s study,
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a competitive exclusion culture (CE) containing bacterial isolates from fecal and cecal contents
of adult birds was orally administered to day-old chicks. This culture reduced Salmonella
presence to below 104 CFU (Stavric et al., 1995). Cox et al., (1992) utilized the concept of CE
culture through an in ovo delivered dose to determine if any reduction in Salmonella
concentrations could be obtained. However, hatchability was reduced from 56% to 78% in eggs
inoculated onto the air cell and from 0% to 44% in eggs inoculated into the amnion. The
incidence of Salmonella was reduced when the culture was undiluted and inoculated onto the air
cell. However, hatchability was reduced to 56%.
After 5 years, Meijerhof and Hulet, (1997) evaluated a commercial competitive exclusion
culture using in ovo administration techniques. The product was administered onto the air cell
and in the small end of the egg. The administration of the competitive exclusion culture resulted
in a significant reduction in hatchability to less than 86% when inoculated onto the air cell and
less than 5% when inoculated into the small end of the egg, when compared to the in ovo
inoculation of water as control which resulted in hatchability percentage higher than 86%. For all
treatments containing the CE culture, the chicks that hatched presented bacterial contamination
(Meijerhof and Hulet, 1997). In this same year, (Edens et al., 1997) determined that the use of
specific probiotic cultures for in ovo inoculation could be more beneficial than using a mixture
of unknown cultures (CE). In his study, he evaluated the in ovo inoculation of Lactobacillus
reuteri at doses increasing from 104 to 108 log, a beneficial bacterium that resided symbiotically
in the chicken’s gut and produced an antimicrobial known as reuterin (Edens, 1997). As he
previously proposed, hatchability was not affected by the injection of this known probiotic
culture. Inoculation onto the air cell with increasing concentration of L. reuteri resulted in
hatchability higher than 91%, and higher than 89% when injecting into the amniotic fluid.
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Interestingly, the livability of the birds after hatch seemed to be reduced as the concentration of
L. reuteri inoculated into the amniotic fluid increased to more than seven logs.
After Edens (1997) study, there were not many studies evaluating the use of probiotics in
ovo. Until 2014, de Oliveira et al. (2014), evaluated 7 strains of commercially available
probiotics, out of which he selected two strains that did not impact hatchability, B. subtilis and E.
faecium. In his study, non-specified strains of Lactobacillus reduced hatchability to less than
10% indicating that not all Lactobacillus are beneficial for the embryos. He also evaluated the
ability of these probiotics in reducing the concentration of Salmonella after a challenge 3 days
after hatch. Only E. faecium administered in ovo reduced the number of positive Salmonella
samples (19 positives out of 36 total samples). The authors also used an antibiotic as a positive
control, and only one sample was positive for Salmonella presence. This indicates that although
some of the probiotic cultures can reduce the occurrence of Salmonella, their efficacy is not as
high compared to that of antibiotics.
The in ovo delivery of a CE culture was studied again by (Pedroso et al., 2016), utilizing
a culture obtained from a mature chicken. Hatchability levels were significantly reduced as the
concentration of bacteria increased. However, for the lowest dose (105 CFU of viable cells),
hatchability was similar compared to the non-inoculated chicks at approximately 90%. In this
study, the authors also demonstrated the early establishment of some bacterial genera occurred
within the intestinal tract of newly hatched chicks. In another study, a commercially available
product containing several probiotic cultures such as L. acidophilus, L. casei, E. faecium, and
Bifidobacterium was manually inoculated into the amnion of eggs (Pender et al., 2017). This
study resulted in improved performance when delivered at a 105 CFU dose on the first week of
the hatch and demonstrated the downregulation of some immune parameters. The effect of in
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ovo inoculated probiotics on immune tissues was evaluated by (Slawinska et al., 2014).
However, no information was provided on hatchability and growth performance parameters. In
this study, L. lactis in combination with a prebiotic resulted in higher bursa weight, which was
related to higher antibody production and, therefore, higher immunocompetence.
Automated in ovo inoculation of probiotics
Most of the studies previously mentioned evaluated CE cultures and probiotics by
manually injecting the dose into each egg individually. This method lacks applicability in
industrial settings due to the extensive labor hours, as well as the possible variation between the
persons injecting the eggs. To overcome this issue, there was a need to find a way that
automatically delivers these doses into the egg in a very precise and efficient manner and could
inject hundreds of eggs within minutes. It was then suggested that probiotics could be delivered
into the egg with Inovoject® technology, the first automated system in the U.S. (Ricks et al.,
1999). The automated system for in ovo inoculation has been used to deliver vaccines into the
developing broiler egg for more than 30 years (Marangon and Busani, 2006). The Inovoject®
system replaced the labor-intensive procedure of inoculating the chicks individually in the back
of the neck, and now from 25,000 eggs can be inoculated per hour (Ricks et al., 1999; Williams
and Zedek, 2010). It was demonstrated that the accuracy of injection was also significantly
higher when utilizing the automated Inovoject® system (84%) when compared to manual in ovo
injection (36%) (Wakenell et al., 2002).
More recently, some studies have evaluated the delivery of probiotics in combination
with vaccines through the automated Inovoject® system. The in ovo administration of a
commercially available probiotic culture (no defined probiotic cultures) derived from the poultry
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gastrointestinal tract was evaluated utilizing an automated in ovo injection method combined
with HTV Marek’s vaccine (Teague et al., 2017). Hatchability was not affected by the probiotic
or the in ovo injection procedure, and some improvements were detected in BW possibly due to
improved intestinal morphology. Triplett et al., (2018) evaluated the administration of several
probiotic cultures using Inovoject® technology with no vaccine combination. L. acidophilus, B.
subtilis, and Bifidobacterium were evaluated in separate studies and out of the three cultures
evaluated, L. acidophilus at different concentrations presented the highest hatchability at more
than 90%. The in ovo injection of Bifidobacterium caused a slight reduction in hatchability
between 75 to 88%. However, B. subtilis at concentration ranging from 103 to 106 CFU/50µL
reduced hatchability to less than 50%, and as low as 5% for the 104 and 105 CFU concentrations.
The delivery of a probiotic E. faecium onto the egg air cell using an automated injection
system was evaluated by (Coskun et al., 2015). Hatchability was not negatively affected by the
treatment, and no differences were obtained in growth performance on a 42 day grow-out with
no probiotic inclusion in the feed. However, there was a slight change in microbiota, where lactic
acid bacteria concentrations increased due to the administration of E. faecium. In another study,
E. faecium and L. animalis were evaluated alone or in combination at a 106 CFU/50µL dose
combined with an HVT Marek’s vaccine, using Inovoject® technology. The HVT vaccine
injection without probiotic inclusion served as a control. In this trial, hatchability was not
impacted by any of the treatments, and no differences were detected in weight gain during a 42
day grow-out. Some alterations were obtained in intestinal morphology such as intestinal tissue
length and weight which led to a slight reduction in FCR (Beck et al., 2019).
The concept of in ovo inoculation of probiotics and CE cultures re-emerged with
improved methods and technology, resulting in less effects in hatchability compared to the
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studies conducted in the 1990’s. Some studies evaluated the effects on microbiota, physiological
characteristics of different immune organs, as well as the effects on overall performance after
hatch. It is clear that these effects can vary significantly according to the site of injection and
method of injection, but mostly due to the type of probiotic bacteria utilized. In some studies,
certain types of probiotic bacteria commonly used in broiler feed resulted in unexpected
reductions in hatchability even with the use of automated injection procedure to guarantee the
correct delivery of each dose. There is a need to thoroughly evaluate different probiotic cultures
as different concentrations and determine their effects on more specific parameters. These
parameters should focus on the proposed mechanisms of actions of each probiotic culture, such
as competitive exclusion of other pathogenic agents, secretion of antimicrobial substances,
modulations in the intestinal morphology, as well as the immune parameters, and determine if
any modulations are occurring earlier compared to the in feed delivery. Determining the
beneficial effects of the in ovo administration of specific bacterial cultures could lead to an
improved application of these methods. Further research is also necessary to determine if the
benefits obtained through a single probiotic dose delivered in ovo can be maintained throughout
the grow-out period.
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CHAPTER III
DISCOVERING THE OPTIMAL CONCENTRATION OF AN ENTEROCOCCUS FAECIUM
BASED PRODUCT TO ENHANCE BROILER HATCHABILITY, LIVE PERFORMANCE,
AND INTESTINAL MORPHOLOGY
Abstract
Previous studies have suggested the use of probiotics as an alternative to antibiotics to
enhance broiler performance. The administration of probiotics in feed has been widely explored;
however, few studies have evaluated the in ovo inoculation of probiotics. Therefore, the
objective was to evaluate the impact of in ovo inoculation of different concentrations of
Gallipro® Hatch (GH), an Enterococcus faecium based probiotic, on hatchability, live
performance, and gastrointestinal parameters. Ross x Ross 708 fertile eggs were incubated and
on d 18 inoculated with the following treatments: 1) 50 µL of Marek’s vaccine (MV), 2) MV and
1.4x105 cfu GH/50µL, 3) MV and 1.4x106 cfu GH/50µL, 4) MV and 1.4x107 cfu GH/50µL. On
d of hatch, chicks were weighed, feather sexed, and hatch residue was analyzed. Males (640)
were randomly assigned to 40-floor pens. On d 0, 7, 14, and 21 of the grow-out, performance
data were collected. One bird from each pen was used to obtain yolk weight and intestinal
segment weight and length. Hatchability was not impacted by any GH treatment (P=0.58). On d
0, yolk weight was lower for all treatments compared to MV alone. On d 0-7, feed intake was
lower for 105 and 107 GH; the FCR was lower for all treatments compared to MV alone (P=0.05;
P=0.01, respectively). From d 14-21, the 107 GH treatment had higher BW gain (P=0.05). On d
61

0-21, 107 GH had a lower FCR than MV alone (P=0.03). On d 0, all GH treatments resulted in
heavier tissues and longer jejunum, ileum and ceca lengths compared to MV alone (P<0.05).
Spleen weight was higher for 105 and 107 GH compared to MV alone. In conclusion, GH does
not affect hatchability, and some concentrations improved live performance through the first 21 d
of the grow-out. These improvements could result from the increased yolk absorption and
improved intestinal and spleen morphology seen in this study.
Introduction
The use of antibiotics as growth promoters has been banned in the European Union for
more than a decade (Phillips, 2007). Even though there is no ban in the U.S., consumers are
demanding antibiotic-free animal products (Phillips, 2007). The search for probiotics as
alternatives to antibiotics has increased over the past years (Fallah et al., 2013). When utilized as
feed supplements, probiotics are advantageous for poultry health and overall performance
(Patterson and Burkholder, 2003; Kabir, 2009; Eckert et al., 2010; Karimi et al., 2010;
Hashemzadeh et al., 2010; Mountzouris et al., 2010; Youssef et al., 2011; Liu et al., 2012). The
most used probiotic species are Lactobacillus, Bacillus, Enterococcus spp., and Bifidobacterium
(Patterson and Burkholder 2003; Fontana et al., 2013).
Enterococcus spp. are a group of Gram-positive lactic acid bacteria, commonly isolated
in the form of single, paired, or short-chain cocci. They are known to be ubiquitous and can be
found in foods of animal origin due to their ability to colonize the intestines of both humans and
animals (Giraffa, 2003; Cocolin et al., 2007). Although there are many virulent and infectious
strains of Enterococcus, certain E. faecium serotypes can reduce pathogens through the
production of enterocins to promote a beneficial microbial balance within the gastrointestinal
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tract of the host (Cleveland et al., 2001; Franz et al., 2011; Hanchi et al., 2019). Some E. faecium
serotypes are therefore considered to be safe for use in the fermentation of meats and dairy
products, as well as a probiotic species to reduce intestinal E. coli infections and promote the
development of the immune system in broilers (Cao et al., 2003; Franz et al, 2011). The use of E.
faecium based probiotics has become more prevalent due to their resistance to bile salts and low
pH encountered in digestion, allowing the probiotic strain to reach the small intestine to exert its
beneficial effects (Zommiti et al., 2018).
E. faecium has been previously evaluated as a probiotic additive in feed and has resulted
in improved growth performance and intestinal morphology in broilers challenged with E. coli
(Mountzouris et al., 2010). When added into the broiler diet, it has also improved the FCR, meat
yield, and meat quality (Zheng, 2016). This probiotic has also been found to reduce pathogenic
bacteria such as C. perfringens and E. coli within the intestinal microflora (Samli et al., 2010;
Huang et al., 2018). Most importantly, beneficial bacteria pre-existing in the bird’s microbiota,
such as Lactobacillus, are not affected by the presence of E. faecium (Kacániová, 2006; Samli et
al., 2007; Cao et al., 2012).
The ability of E. faecium to improve broiler performance when added to the bird’s feed
has led to more questions on its applicability to enhance its beneficial effects further. It has
become of recent interest to evaluate the delivery of probiotics such as E. faecium in ovo, and
determine its ability to establish a healthy microbiota, earlier, within the chick’s life. Chr.
Hansen® developed Gallipro Hatch, an E. faecium based product for in ovo inoculation. With
this being a relatively new product, it needs to be evaluated to determine its effect on the embryo
and, consequentially, the hatched chick. For this reason, research within this paper utilized
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different concentrations of E. faecium isolated from the commercial product, and in ovo
inoculated them on d 18 of incubation using Inovoject® Technology. Although Inovoject
technology was originally developed for in ovo delivery of vaccines to the embryo (Sharma and
Burmester, 1982; Gildersleeve et al., 1993), it has been recently verified to be effective for the
delivery of probiotics (Triplett et al., 2017). Thus, the objective of this study was to determine if
the early administration of E. faecium at different concentrations, using commercial in ovo
inoculation technology will affect hatchability, broiler performance, and intestinal parameters, as
well as immune tissue morphology within broilers.
Materials and Methods
Incubation
For this study, all animals were treated in compliance with the Guide for the Care and
Uses of Agriculture Animals in Research and Teaching (Federation of Animal Science Societies,
2010) and the Mississippi State University Institutional Animal Care and Use Committee
(IACUC Animal Welfare Assurance #A3160-01).
A total of 2,300 Ross x Ross 708 fertilized eggs were obtained from commercial breeder
hens at 55 weeks of age and stored for 3 d at 20°C before setting. Eggs were labeled according to
treatment, flat, and egg number. Simultaneously, excessively dirty and broken eggs were
removed. A total of 2,160 eggs were distributed into 18 egg flats for each treatment (540 eggs
per treatment) and randomly placed into 2 NatureForm Incubators (Model NMC-1080,
Jacksonville, FL, USA). Each treatment was represented on each level within the incubator. The
incubators were sanitized with 70% ethanol prior to egg placement. The dry and wet bulb
temperatures were set at 37.5°C ± 0.1 and 28.9°C ± 0.1, respectively. On d 10 of incubation,
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eggs were candled to discard eggs that were infertile, cracked, contaminated, or presented early
dead embryos. On d 18 of incubation, all eggs were inoculated according to treatment. After in
ovo inoculation, eggs belonging to each treatment were transferred into 18 previously sanitized
hatching baskets that were equally distributed among 3 Georgia Quail Farm® hatcher units (6
baskets/hatcher, 3 hatchers/treatment). Eggs for each treatment were set into 3 hatchers to avoid
cross contamination (12 total hatchers; GQF MFG, 1502 Digital Sportsman incubator; Savannah,
GA) until d 21 of incubation. The hatcher dry and wet bulb temperatures were set at 36.9°C ± 0.1
and 30°C ± 0.1, respectively. Sterile water was added each day at the same time, to maintain the
desired humidity level.
Treatments
The commercially available Gallipro® Hatch product utilized in this study contained 109
cfu/g of E. faecium. One gram of the product was reconstituted in Tryptic soy broth (TSB
Millipore Sigma, St. Louis, MO) and incubated at 37 °C under anaerobic conditions (VWR™
International, 1535 incubator, Cornelius, OR, USA). After 24 h of incubation, the bacterial
culture was 10-fold serially diluted, plated onto Bile Esculin agar plates (BEA; Millipore Sigma,
St. Louis, MO), and incubated for 24 h at 37 °C. To obtain the different concentrations of E.
faecium desired for each treatment, a 109 cfu/mL culture was 10-fold serially diluted and
centrifuged at 4,000 rpm for 5 min to obtain a pellet. The supernatant was removed, and the
pellet was reconstituted with sterile diluent. All treatments were prepared on the day of
inoculation and individually distributed into 800 mL bags of a commercial sterile diluent. A
standard HVT vaccine (16,000 doses/800 mL bag; Merial Select, Inc., Gainesville, GA) was
aseptically added to each diluent bag. The applied treatments included: 1) 50 µL Marek’s disease
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vaccines (HVT vaccine) and no probiotic (MV alone), 2) Marek’s disease vaccine + ~105 cfu
GH/50 µL, 3) Marek’s disease vaccine + ~106 cfu GH/50 µL, 4) 50µL Marek’s disease vaccine +
~107 cfu GH/50 µL. The diluent bags containing each treatment were kept on ice until their

utilization. During the in ovo inoculation procedure, 50 µL were collected from each treatment,
and spread onto the appropriate agar plates to confirm that the correct concentration of bacteria
was delivered for each treatment.
Inoculation procedure
On d 18 of incubation, one egg from each flat was set aside for embryo staging. Each flat
of developing eggs was inoculated at a time. Eggs were inoculated on their large end, into the
amniotic sac. The needle punctured each egg at a depth of 2.49 cm to deliver each 50 µL
concentration automatically. The different concentrations of the probiotic culture were
inoculated in ascending concentration of bacteria to ensure the correct dosage was applied
according to each treatment. However, between each treatment applied, a sanitization cycle was
conducted to eliminate any contamination in the Inovoject® equipment. After each cycle, 50µL
were collected and spread onto Tryptic Soy Agar (TSA; Millipore Sigma, St. Louis, MO) plates
to confirm that no bacterial contamination occurred between treatments. After all treatment
inoculations, the eggs removed from each flat were in ovo inoculated with 50µL of a Coomassie
blue dye and immediately euthanized via CO2 asphyxiation. Each embryo was analyzed to
confirm that the inoculated eggs were in the appropriate stage of development for 18 d of
incubation. Also, the presence of the dye surrounding the embryo’s body through the amniotic
fluid confirmed that the inoculation was correctly delivered in the amniotic fluid and did not
puncture the embryo’s tissue.
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Hatch and grow-out
On d 21 of incubation, all hatched and unhatched eggs were removed from the hatching
baskets. Unhatched eggs were counted and evaluated through hatch residue analysis to determine
the developmental stage of the embryo before its death, according to Aviagen’s guidelines
(“How to… Break Out and Analyze Hatch Debris,” 2017). The number, treatment, and stage of
each egg were recorded, including early dead, mid-dead, late dead, pipped, and contaminated.
Hatched chicks were counted and weighed to determine the hatch of fertile eggs and average
chick weight. Chicks and embryos were treated in accordance with the Guide for the Care and
Uses of Agricultural Animals in Research and Teaching (FASS, 2010).
Hatched chicks were weighed, feather sexed, and 640 males were moved to a grow-out
facility where they were raised through a 21 d grow-out cycle. Male chicks were assigned to
each pen (16 chicks/ pen), with a total of 10 pens for each treatment. The treatments were
assigned to 10 blocks down the length of the house, skipping a pen to avoid cross-contamination
within birds of different treatments. Each floor pen was equipped with one hanging feeder, 3
nipple drinkers and top-dressed with fresh wood-shavings litter. The chicks were set at a 23L: 1d
photoperiod from d 0 to 7 and a 20L: 4d photoperiod from d 8 to 21. A commercial temperature
program was followed as recommended by Aviagen (“Ross Broiler Management Manual”,
2009). A regular corn and soybean meal diet was provided in crumble form for the two feeding
phases: starter feed from d 0 to 14 and grower feed from d 14 to 21 following Ross 708
guidelines (“Ross 708 Nutrition Specifications”, 2014). Water and feed were provided adlibitum. Feed intake (FI) and body weight gain (BW gain) were recorded on d 7, 14 and 21.
Daily mortality and dead bird weight were recorded to calculate feed conversion ratio (FCR).
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Sampling
On d 0, 7, 14 and 21 of the grow-out, a bird from each pen was randomly selected to be
weighed, humanely euthanized, and aseptically necropsied to access their digestive tract (10
birds/ treatment). The crop, gizzard, duodenum, jejunum, ileum, and cecum were collected to
obtain their individual weight and length. The spleen, bursa, and yolk were collected to obtain
their weight.
Statistical analysis
All data were analyzed using SAS v 9.4 (SAS Institute, Cary, NC). Hatch of transfer and
hatch residue data were analyzed using a completely randomized design where each flat of eggs
served as the experimental unit (18 flats/treatment). BW gain, FCR, FI, intestinal parameters, as
well as yolk, spleen, and bursa weight data were analyzed using a randomized complete block
design with a split-plot over time. Each pen served as an experimental unit, and there was a total
of 10 pens for each treatment. Means were separated using Fisher’s protected LSD and were
considered significantly different if the p-value was ≤ 0.05 (Steel and Torrie, 1980).
Results
Inoculation procedure and E. faecium concentration
The embryo staging analysis conducted on the d of in ovo inoculation demonstrated that
the procedure was conducted at the right stage of development. As expected for this day of
incubation, the embryos showed a 3-lobed yolk sac, and their intestines were mostly enclosed
within the embryos’ abdominal cavity. The delivery of the inoculum into the amnion was also
confirmed with the presence of Coomassie blue dye surrounding the embryo’s body and,
therefore in the amniotic fluid. None of the embryos presented punctures in their bodies. The
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concentration of each E. faecium recovered on the day of inoculation were confirmed to be: 1)
Marek’s disease vaccine alone (MV alone), no bacterial growth; 2) for the 105 cfu GH/50 µL
concentration, 4.5 x 105 cfu GH/50 µL; 3) for the 106 cfu GH/50 µL concentration, 6.5 x 106 cfu
GH/50 µL; and 4) for the 107 cfu GH/50 µL concentration, 9.4 x 107 cfu GH/50 µL.
Hatch and growth performance
For hatch of transferred eggs, there were no differences detected among treatments when
compared to the control (P>0.05; Table 3.1). No differences were detected on early, mid, and
late dead embryos, as well as for pipped, contaminated, and culled embryos. Average chick
weight was not different among any of the treatments evaluated (P>0.05; Table 3.1). Differences
were seen in growth performance among treatments and the days of the grow-out (Table 3.2).
From d 0-7, feed intake was lower for the 105 and 107 cfu GH/50 µL concentration when
compared to the Marek’s vaccine (MV) alone treatment, and the 106 cfu GH/50 µL concentration
(P=0.049). On d 0-7, the FCR was on average 12 points lower for all GH inoculated birds when
compared to MV alone treatment (P=0.014). No differences were detected in BW gain
(P=0.985). From d 7-14, no differences were detected for any growth performance variables
evaluated.
From d 14-21 of the grow-out, some differences were detected, where a higher BW gain
was obtained by the highest GH concentration (107 cfu GH/50 µL) compared only to the lowest
GH concentration (105 cfu GH/50 µL), and not to the other treatments (P=0.045). For FCR, there
was a trend (P=0.068) where the increasing GH concentrations caused a numerical decrease in
FCR, ultimately reducing the FCR numerically by 11 points compared to MV alone.
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The overall broiler performance from d 0-21 resulted in improvements in FCR. FCR was
significantly reduced by the highest concentration of probiotic (107 cfu GH/50 µL), resulting in a
9-point difference compared to the MV alone treatment and the lowest concentration inoculated
(105 cfu GH/50 µL) (P=0.049). There was a trend in BW gain (P=0.073) where birds were
numerically heavier for the highest concentration of the probiotic inoculated (107 cfu GH/50 µL)
when compared to the rest of the treatments, especially the lower concentrations of GH (105 cfu
GH/50 µL, 106 cfu GH/50 µL).
Immune tissues and yolk weight
Treatment effects were detected for yolk weight relative to BW on d 0, where a decrease
in yolk weight was observed for all GH treatments (P=0.0003) when compared to MV alone.
Differences were also detected for spleen weight relative to BW, which was higher for the 105
cfu GH/50 µL and 107 cfu GH/50 µL treatments when compared to the MV alone treatment
(P=0.013). Differences were also seen for bursa weight relative to BW (P=0.448) (Table 3.3).
Intestinal relative weight and length
Intestinal weight relative to chick BW resulted in treatment by day interactions
throughout the 21-d grow-out period for the gizzard, duodenum, jejunum, ileum and ceca
(P=0.0001, for all tissues; Table 3.4). On d 0, the gizzard, duodenum, jejunum, ileum and ceca
weights were higher for all probiotic treatments compared to the MV alone treatment. However,
by d 7, this increase in weight was lost, and the jejunum, ileum, and ceca weights were lower
compared to the MV alone treatment, while the gizzard and duodenum were not different. On d
14, the duodenum weight relative to BW was higher for the 106 cfu GH/50 µL treatment
compared to all other treatments. The weight of the ileum relative to BW was higher for the 106
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cfu GH/50 µL treatment when compared to the 107 cfu GH/50 µL treatment. No differences
were detected among treatments on d 21.
Intestinal length of the jejunum, ileum and ceca relative to the chicks’ BW (cm/100g)
were also influenced by the different GH concentrations, resulting in treatment by day
interactions (P =0.01, P=0.02, P=0.03, respectively; Table 3.5). On d 0 of hatch, all GH
inoculated treatments resulted in longer relative jejunum and ileum lengths when compared to
the MV alone treatment. Whereas for the ceca, birds inoculated with 106 cfu GH/50 µL
demonstrated greater length compared to the other treatments. On d 7, jejunum and ceca relative
lengths were similar among all inoculated treatments. However, ileum length was higher in the
107 cfu GH/50 µL treatment compared to the MV alone treatment. On d 14 and 21, no other
differences were observed for any other tissue (P>0.05).
Discussion
Hatchability and hatch performance
In the present study, commercial in ovo inoculation technology was used to administer
different concentrations of a commercially available Enterococcus faecium (E. faecium) into the
amnion of fertile broiler eggs. It has been previously demonstrated that commercial in ovo
injection increases the accuracy of injection from 36.1% to 83.8% compared to manual injection
(Wakenell et al., 2002). However, most of the existing literature evaluating in ovo administration
utilized manual procedures for injection, which lacks applicability to commercial settings.
Previous studies evaluating the injection of competitive exclusion culture derived from chicken
intestinal contents reduced hatchability levels as low as 0-5% when manually injecting into the
amnion, and 56-84% when delivered onto the air cell (Cox et al., 1992; Maijerhof and Hulet,
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1997). However, it was later shown that the manual in ovo injection of specific probiotic cultures
such as Lactobacillus or Bacillus, whether into the amnion or onto the air cell, does not seem to
impact hatchability, thus validating the early use of probiotic cultures (Edens et al., 1997; De
Oliveira et al., 2014). More recently, studies have not detected any differences in hatchability
between a control and in ovo inoculated probiotic treatments (Pender et al., 2017; Teague et al.,
2017; Beck et al., 2019).
Triplett et al., (2018) evaluated the use of commercial in ovo injection. In their study, the
percent hatch of transfer of non-inoculated eggs, as well as a Lactobacillus and a
Bifidobacterium injection, was approximately 90%. However, different concentrations of a
specific B. subtilis strain reduced hatchability to as low as 10% to 50%. In their study, the
decreased hatch for B. subtilis compared to the two other strains evaluated was attributed to a
bacterial effect and not the in ovo inoculation procedure. However, the negative impact on
hatchability obtained by injecting B. subtilis was not expected since this probiotic culture has
been previously found to be beneficial for broilers when added to their feed (Jeong and Kim,
2014; Bai et al., 2017). Therefore, it is likely that not all probiotic bacteria are suitable for in ovo
inoculation, even if they are commonly known to be safe for use in feed. For this reason, the
bacteria to be inoculated, even if it is a well-known probiotic, needs to be evaluated prior to
commercial application.
In the present study, hatch of transfer for all treatments, including Marek’s vaccine (MV)
alone, as well as MV with increasing concentrations of the probiotic was between 91-94% and
showed no differences among treatments. Additionally, on the day of hatch, no differences were
observed in contaminated embryos, early, mid, and late dead embryos or average chick weight
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among any of the treatments inoculated. Similar results were obtained by the in ovo inoculation
of a non- commercial strain of E. faecium (Beck et al., 2019). These results are promising for the
use of a commercial in ovo procedure in the administration of probiotics without negatively
impacting hatchability. This verifies the commercial in ovo inoculation as a viable method for
the delivery of probiotics, and this specific serotype of E. faecium as a beneficial culture, which
is safe for in ovo administration.
Live performance
E. faecium, as a probiotic culture, has been widely evaluated as a feed supplement in
poultry diets (Cao et al., 2003; Samli et al., 2007; Samli et al., 2010; Zhao et al., 2013;
Capcarova et al., 2009; Huang et al., 2018). The supplementation of E. faecium in broiler feed
has shown improved BW gain (Samli et al., 2010). Other studies have demonstrated reduced E.
coli (Cao et al., 2003; Capcarova et al., 2009; Gheisar et al., 2016; Awad et al., 2018; Huang et
al., 2018) and a slight reduction of Salmonella concentrations in the ceca (De Oliveira et al.,
2014). E. faecium alone and in combination with a prebiotic dried whey has also been shown to
increase BW gain, reduce the FCR and increase lactic acid bacteria in the birds’ ileum and
excreta (Samli et al., 2007). However, other studies have shown that E. faecium alone does not
cause changes in BW, FCR, or FI through a 42 day grow-out (Zhao et al., 2013). Although many
improvements have been seen with the use of this probiotic in feed, little research has been
conducted to evaluate the use of E. faecium in ovo to evaluate its effect on hatch and growth
performance.
In previous research, Majidi-Mosleh et al., (2017) evaluated the manual in ovo injection
of a 107 cfu dose of B. subtilis, E. faecium, and P. acidilacti individually into the amnion of
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fertile eggs and found no differences in growth performance. Coskun et al., (2015) evaluated the
in ovo delivery of E. faecium and dried whey. Although they also utilized an automated machine
for in ovo injection, the probiotic concentration was delivered onto the air cell. In their study, no
differences were seen in growth performance for any E. faecium inoculated treatments through a
21-day grow-out. In the present study, the probiotic E. faecium was delivered into the amnion,
and differences in growth performance were observed throughout most of the grow-out cycle,
most prominent from d 0-7 and d 0-21. From d 0-7, the FCR was reduced by the different GH
treatments compared to MV alone treatment, due to a reduction in FI. However, no differences
were detected in BW gain. The improvement in FCR and the trend in BW gain, especially by the
highest GH concentration (107 cfu GH/50 µL), were carried through d 21 of the grow-out. This
could mean that this serotype of E. faecium at a higher concentration can colonize and multiply
in the chicken’s gastrointestinal tract, thus exerting its beneficial effects for a more extended
period (Skjøt-Rasmussen et al., 2019). The delivery of the probiotic into the amnion, as
compared to the air cell (Coskun et al., 2015), possibly made the probiotic available earlier for
the embryo to absorb, as suggested by Castañeda et al., (2018). The earlier availability of the
probiotic concentration within the bird’s gastrointestinal tract and its ability to remain within
may have led to the improvements seen in performance characteristics throughout the grow-out
cycle.
Intestinal morphology and yolk weight: effects on performance
The different probiotic concentrations seemed to alter the morphology of the chicks’
intestine. The probiotic doses increased gizzard, duodenum, jejunum, ileum, and ceca weight,
especially on d 0-7 post-hatch. Similarly, all probiotic doses increased jejunum, ileum, and ceca
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length compared to the control, except for the lowest E. faecium concentration used (105 cfu
GH/50 µL). These increases in small intestine weight have also been previously detected with
the supplementation of E. faecium in poultry and piglet feed (Ciro et al., 2015; Awad et al.,
2009). The in ovo administration of other serotypes of E. faecium alone or in combination with
dried whey have also demonstrated an increased jejunum and ileum weight (Coskun et al., 2015)
and length (Beck et al., 2019). The small intestine’s ability to digest and absorb nutrients is
highly related to intestinal structure, such as its weight and length (de Verdal et al., 2010;
Moghaddam and Alizadeh, 2012). In this study, the in ovo delivery of E. faecium resulted in
heavier and longer segments of the small intestine, mostly during the first days of the grow-out.
It is believed that these early modulations in intestinal morphology resulted in an efficient
nutrient absorption, which could be responsible for the improvements obtained in growth
performance parameters. Other studies had also shown modulations in some segments of the
small intestine, such as increased ileum villus height (Coskun et al., 2015) and increased jejunum
and ileum weights on d 14 and 21 of the grow-out due to the in ovo probiotic inclusion (Beck et
al., 2019). However, their changes in intestinal morphology were not enough to elicit a
significant improvement in growth performance as compared to the ones obtained in this study.
The modulations obtained in intestinal morphology, especially in the first 7 days of the
grow-out, could be related to the increased absorption of egg yolk caused by all probiotic
inoculated treatments. The eggs yolk is known to be the main nutrient supply for growth of the
embryos and a major source of energy for the hatching bird during its first days (Nangsuay et al.,
2011; Sahan et al., 2014). During the first 48 h post-hatch, the yolk is the primary source of
energy for intestinal development, thus preparing the chick for its transition to the consumption
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of a regular basal diet (Jamroz et al., 2004; Uni, 2006, Yegani and Korver, 2008). In the present
study, all E. faecium inoculated concentrations resulted in a more rapid yolk utilization compared
to the MV alone treatment on d 0 post-hatch. The in ovo inoculation of E. faecium, seemed to
stimulate a faster consumption of these nutrients to be utilized not only for hatching energy but
also for enhanced intestinal development. Previous studies demonstrated that the uptake of yolk
by the small intestine can be improved through the in ovo injection of exogenous nutrients into
the amniotic fluid (Uni, et al., 1998; Geyra et al., 2001; Noy and Sklan, 2001; Noy et al., 2001;
Tako et al., 2004). However, it is exceptional that the in ovo administration of a probiotic culture
has the potential to elicit and improve yolk absorption that could lead to further improvements in
gut morphology and broiler performance.
Treatment effect on spleen weight
The impact of the in ovo inoculation of E. faecium on immune organ development was
evaluated in this study. It was observed that all in ovo inoculated concentrations of E. faecium
yielded increased spleen weight compared to the MV alone treatment. These results are in
agreement with previous research stating that the administration of probiotics in ovo can
stimulate important immune tissues (Castañeda et al., 2019), as previously seen in probiotic fed
broilers (Kabir et al., 2004; Willis et al., 2007). The spleen is a secondary lymphoid structure
characterized by aggregated lymphocytes and antigen-presenting cells. It has been previously
demonstrated that there is a strong correlation between the weight of immune tissues such as the
spleen and bursa and their immune competence through the increased level of antibody
expression (Kabir et al., 2004; Slawinska et al., 2014). The detection of bacteria, whether
pathogenic or probiotic, seems to stimulate an immune response in chickens (Hughes, 2005). The
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early detection of probiotic bacteria could, therefore, result in more rapid “maturation” of the
immune system. Although no differences were seen in bursa weight, the increased spleen weight
could be promising for earlier protection against diseases within the first week after hatch as
opposed to a three-week post-hatch immune maturation (Fagerland and Arp, 1993). However, it
still needs to be determined if these immuno-modulations are strong enough to suppress an E.
coli, Salmonella, or coccidiosis challenge in chicks during a full grow-out period.
Conclusions
The results of this study indicate that none of the concentrations of E. faecium harmed
hatchability. Although the lower GH concentrations evaluated resulted in some modulations, the
107 cfu GH/50 µL concentration of E. faecium resulted in numerical improvement in BW gain
and significant improvements in FCR. However, all GH concentrations increased intestinal
weight and lengths, particularly one-week post-hatch. The intestinal modulations obtained are
believed to be a result of a faster yolk absorption by E. faecium treated embryos. These changes
in intestinal morphology may lead to better nutrient absorption, resulting in improved growth
performance. Increases in spleen weight were also seen on the day of hatch for all E. faecium
concentrations evaluated. This modulation may have significant implications for an earlier
development of a “mature” immune system even before the embryo hatches, which could
become more efficient as the chicks grow.
The 9-point improvement in FCR seen in this study could yield great economic margins
in industrial production systems. These improvements, as well as the possible boosting of the
immune system, have a great potential to establish in ovo inoculated probiotics, such as E.
faecium, as viable alternatives to antibiotics. However, further research is needed to determine if
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these improvements will be carried through a 49-day grow-out and if these modulations,
especially of the spleen, are enough to confer protection against parasitic and pathogenic
challenges. Most importantly, additional research should evaluate if the modulations obtained
can reduce the overall incidence of unwanted bacteria in the broiler house and ultimately in the
processing plant while maintaining an improved growth performance.
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Tables
Table 3.1

Effect of the in ovo inoculated MV Alone (Marek’s vaccine with not addition of probiotic), and Gallipro Hatch (GH) at
105 cfu GH (MV + 105 cfu GH/50µL), 106 cfu GH (MV + 106 cfu GH/50µL), and 107 cfu GH (MV + 107 cfu GH/50µL)
on hatch parameters 1
MV Alone

105cfu GH

106 cfu GH

107 cfu GH

Hatch of transfer

94.0

94.3

94.4

91.96

0.58

1.399

Infertile embryos

0

0.21

0

1.1

0.22

0.429

Early dead embryos

0

0

0

0.26

0.39

0.132

Mid dead embryos

0.41

0.43

0.35

0.2

0.94

0.287

Late dead embryos

4.54

4.26

4.35

5.46

0.78

0.914

Pipped embryos

0.65

0.62

0.91

1.01

0.92

0.469

Contaminated
embryos

0.19

0

0

0.21

0.57

0.143

Cull embryos

0.22

0

0

0

0.39

0.111

0.26

0.424

Treatments

Avg. Chick Weight (g)
44.22
44.1
43.11
43.68
Means in a row not sharing a common superscript are different (P ≤ 0.005)
1
Observed means are calculated from 18 replicate values using a flat of eggs as the experimental unit
a-c
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P-value SEM

Table 3.2

Live performance parameters of broilers in ovo inoculated with different concentrations of Gallipro Hatch (GH)
Enterococcus faecium based probiotic on d 18 of incubation: MV Alone (Marek’s vaccine with not addition of
probiotic), 105 cfu GH (MV + 105 cfu GH/50µL), 106 cfu GH (MV + 106 cfu GH/50µL), and 107 cfu GH (MV + 107 cfu
GH/50µL) 1
Day of the
grow-out
d 0-7

Performance
parameter

MV Alone

105cfu GH

106 cfu GH

107 cfu GH

P- value

SEM

0.153a
0.138b
0.143ab
0.141b
0.049
0.0037
Feed intake (kg)
0.111
0.113
0.113
0.112
0.985
0.0043
BW gain (kg)
a
b
b
b
1.384
1.273
1.265
1.265
0.014
0.0264
FCR
d 7-14
Feed intake (kg)
0.355
0.339
0.340
0.379
0.328
0.0166
BW gain (kg)
0.238
0.222
0.224
0.266
0.224
0.0165
FCR
1.548
1.563
1.531
1.438
0.228
0.0469
d 14-21
0.576
0.532
0.555
0.593
0.183
0.0202
Feed intake (kg)
ab
b
ab
a
0.400
0.378
0.400
0.446
0.045
0.0173
BW gain (kg)
1.324
1.290
1.277
1.213
0.068
0.0300
FCR
d 0-21
1.083
1.006
1.035
1.114
0.148
0.0356
Feed intake (kg)
0.752
0.706
0.734
0.821
0.073
0.0320
BW gain (kg)
a
a
ab
b
1.450
1.433
1.422
1.360
0.049
0.0238
FCR
a-c
Means in a column not sharing a common superscript are different (P ≤ 0.05)
1
Observed means are calculated from 10 replicate values using one randomly chosen bird per pen and each pen as the experimental
unit (18 birds/pen; 180 total birds/treatment)

80

Table 3.3

Treatment effect for weight of immune tissues, and yolk weight relative to body weight of broilers in ovo inoculated
with different concentrations of Gallipro Hatch (GH) Enterococcus faecium based probiotic on d18 of incubation: MV
Alone (Marek’s vaccine with not addition of probiotic), 105 cfu GH (MV + 105 cfu GH/50µL), 106 cfu GH (MV + 106
cfu GH/50µL), 107 cfu GH (MV + 107 cfu GH/50µL) 1

Tissue (%)

MV Alone

105cfu GH

106 cfu GH

107 cfu GH

P-value

SEM

Yolk on d 02
10.55a
6.408b
6.558b
6.281b
0.0003
0.6957
b
a
ab
a
Spleen
0.093
0.113
0.099
0.113
0.013
0.0048
Bursa
0.13
0.135
0.261
0.154
0.448
0.0646
a-b
For each tissue, means in a row not sharing a common superscript are different (P ≤ 0.005)
1
Observed means are calculated from 10 replicate values using one randomly chosen bird per pen and each pen as the experimental
unit (18 birds/pen; 180 total birds/treatment)
2
Yolk weight obtained only on d 0. No egg yolk was present for most of the replication units during the remaining days of the growout cycle.
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Table 3.4

Treatment by day interaction for small intestine weights relative to BW (%) of broilers in ovo inoculated with different
concentrations of the probiotic Enterococcus faecium from Gallipro Hatch (GH): MV (Marek’s vaccine with not
addition of probiotic), 105 cfu GH (MV + 105 cfu GH/50µL), 106 cfu GH (MV + 106 cfu GH/50µL), and 107 cfu GH
(MV + 107 cfu GH/50µL)
Gizzard

Day of
growout
d0
d7
d 14
d 21
p-value
SEM

MV
Alone
5.793b
4.062c
3.028d
2.328e

105 cfu 106 cfu
GH
GH
a
8.955
8.839a
c
4.189
4.161c
3.277d
3.063d
e
2.231
2.155e
0.0001
0.1593

Duodenum
107 cfu
GH
8.867a
4.113c
2.985d
2.007e

MV
Alone
0.955g
1.606bcd
1.343ef
1.094g

105 cfu
106 cfu
GH
GH
ab
1.752
1.845a
cde
1.522
1.593bcd
1.401de
1.643abc
g
0.985
1.123fg
0.0001
0.0803

Ileum
Day of
growout
d0
d7
d 14
d 21
p-value
SEM

MV
Alone
0.896f
2.476a
1.648de
1.485e

105 cfu 106 cfu
GH
GH
bc
2.015
2.140b
b
2.214
1.993bc
de
1.616
1.835cd
1.546e
1.452e
0.0001
0.0842

Jejunum
107 cfu
GH
1.848a
1.449cde
1.350e
1.108g

MV
Alone
1.269i
2.959a
2.207def
1.813h

105 cfu
106 cfu
GH
GH
bcd
2.409
2.333cde
b
2.621
2.577bc
2.106efg 2.440bcd
1.838gh 2.067efgh
0.0001
0.0984

107 cfu
GH
2.658b
2.554bc
2.004fgh
1.934fgh

Ceca
107 cfu
GH
2.083b
1.991bc
1.511e
1.526e

a-h

MV
Alone
0.606gh
0.974a
0.685efgh
0.717defgh

105 cfu
106 cfu
GH
GH
bcdef
0.78
0.910ab
bcdef
0.790
0.893abc
abcde
0.829
0.737cdefg
0.688defgh
0.576gh
0.0001
0.0583

107 cfu
GH
0.850abcd
0.796bcdef
0.644fgh
0.564h

For each tissue, means in a row and column not sharing a common superscript are different (P ≤ 0.05)
Observed means are calculated from 10 replicate values using one randomly chosen bird per pen and each pen as the experimental
unit (18 birds/pen; 180 total birds/treatment)
1
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Table 3.5

Treatment by day interaction for small intestine length relative to body weight (cm/100g) of broilers in ovo inoculated
with different concentrations of the probiotic Enterococcus faecium from Gallipro Hatch (GH): MV alone (Marek’s
vaccine with not addition of probiotic), 105 cfu GH (MV + 105 cfu GH/50µL), 106 cfu GH (MV + 106 cfu GH/50µL),
and 107 cfu GH (MV + 107 cfu GH/50µL) 1

Jejunum
Ileum
Ceca
Day of
growMV
105 cfu 106 cfu 107 cfu
MV
105 cfu 106 cfu 107 cfu
MV
105 cfu 106 cfu 107 cfu
out
Alone
GH
GH
GH
Alone
GH
GH
GH
Alone
GH
GH
GH
b
a
a
a
c
ab
a
b
b
b
a
d0
37.2
42.8
42.4
43.7
31.5
38.3
41.1
36.7
8.29
7.77
9.16
8.06b
d7
24.1c
23.2c
25.1c
26.1c
22.7e
24.2de
24.9de
26.3d
4.22c
4.28c
4.30c
4.64c
d
d
d
de
fg
f
fgh
fghi
d
d
d
d 14
11.7
11.3
11.5
9.17
10.3
11.2
9.95
8.72
2.29
2.51
2.26
1.96de
d 21
6.51e
7.52e
7.48e
6.75e
6.68hi
7.39ghi
6.59i
6.71hi
1.47e
1.54e
1.46e
1.34e
P-value
0.01
0.002
0.03
SEM
1.107
1.193
0.238
a-i
For each tissue, means in a row and column not sharing a common superscript are different (P ≤ 0.005)
1
Observed means are calculated from 10 replicate values using one randomly chosen bird per pen and each pen as the experimental
unit (18 birds/pen; 180 total birds/treatment)
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CHAPTER IV
IN OVO ADMINISTRATION OF BACILLUS SUBTILIS SEROTYPES AND ITS EFFECT ON
HATCHABILITY, PERFORMANCE, AND INTESTINAL MICROFLORA
Abstract
Probiotics have been previously shown to be beneficial to broilers when administered as
feed additives and in ovo. However, it was previously determined that Bacillus subtilis, a
probiotic commonly provided in feed, can be detrimental when in ovo inoculated. Therefore, the
objective of this research was to determine if the serotype of B. subtilis influences hatchability,
chick performance, or intestinal microflora. On d18 of incubation, 540 fertile broiler eggs were
in ovo inoculated with the following treatments (T): T1=Marek’s vaccine (MV), T2=MV + B.
subtilis (ATCC 6051), T3=MD + B. subtilis (ATCC 8473), and T4=MD + B. subtilis (ATCC
9466). It should be noted that in a previous study, T2 was detrimental to hatchability. Inoculated
eggs were transferred to 3 hatchers/T. At hatch, chicks were weighed, feather sexed, and hatch
residue analysis was conducted. 10 males/cage were transferred to the grow-out facility and
placed in 10 cages/T. On d0, 7, 14, and 21 of the grow-out chick and feed were weighed to
obtain performance data. On these days, microbial samples from the ileum and ceca were
collected. Data were analyzed using a completely randomized design for hatchability and
randomized complete block design for live performance and bacterial counts. No differences
were observed for % mid dead, cracked, and cull chicks (P>0.05). However, % hatch of transfer
was greater for T1, T3, and T4 compared to T2 (P<0.001). T2 had significantly higher % late
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dead and % pips when compared to T1, T3, and T4 (P=0.002 and P<0.001). Chicks hatched from
T2 were not vigorous and, thus, not used for the grow-out trial. No differences were observed for
growth performance characteristics (P>0.05). However, the ileum for T3 and T4 had equal or
fewer overall bacterial counts when compared to T1 on every sampling day, except for d21
where T4 had higher bacterial counts (P<0.05). For the ceca, T3 and T4 had equal or fewer
bacterial counts than T1 on every sampling day, except on d14 where T4 had higher aerobic
counts (P<0.05). In conclusion, the serotype of B. subtilis inoculated can have a direct impact on
hatchability. In addition, B. subtilis serotype may modify the intestinal microflora with potential
to reduce pathogenic bacteria present in young broilers.
Introduction
For several years, the poultry industry has been interested in the use of probiotics as an
alternative to antibiotics. The World Health Organization has previously described probiotics as
“live microorganisms which when administered in adequate amounts confer health benefits to
the host” (FAO, 2001). In wild poultry production, probiotics or beneficial bacterial cultures
were acquired naturally as part of the hen’s microflora, which was transferred to the eggs
through the laying process (Ding et al., 2017; Lee et al., 2019) and during the brooding period
(Kabir, 2009). However, due to the commercial settings for fertile egg production, there is no
direct contact with the hen after the eggs is laid, and the maternally provided beneficial cultures
are no longer delivered to the hatchlings (Kabir, 2009). It is therefore thought that the
administration of beneficial bacteria to the chicks before the hatch could result in health benefits
for the bird, thus reducing the susceptibility to incoming challenges.
Competitive exclusion cultures obtained from the intestinal tract of broilers or broiler
breeder hens have been thought to be beneficial if administered to the egg or after hatch to
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outcompete pathogens (Cox et al., 1992; Meijerhof and Hulet, 1997; Al-Zenki et al., 2009;
Schneitz and Hakkinen, 2016). Probiotic cultures have also been evaluated to determining their
effectiveness at controlling specific pathogens such as Salmonella, Campylobacter, E. coli, and
Clostridium in the broiler’s gut, thus preventing or reducing the incidence of infections (La
Ragione and Woodward, 2003; Wine et al., 2009; Youssef et al., 2011; Zhang et al., 2014; Ding
et al., 2017). Probiotics, therefore, modulate the microbial environment in the bird’s gut as well
as their immune system, allowing for better nutrient and energy utilization, resulting in improved
performance (Kabir, 2009; Eckert et al., 2010; Mountzouris et al., 2010; Torshizi et al., 2010;
Youssef et al., 2011; Liu et al., 2012; Lee et al., 2013).
The most commonly used probiotic species in broiler production are Lactobacillus,
Bifidobacterium, Enterococcus, and Bacillus (Kabir, 2009; Park et al., 2018). Each probiotic
culture seems to provide its own set of benefits to the birds. However, Bacillus based probiotics
have several advantages. Bacillus are facultative anaerobe spore formers, and their swift growth
cycle makes their overall handling easier for production in industrial settings (Vazquez, 2016).
Contrary to other probiotic bacteria, Bacillus spores can withstand high-temperature feed
processes. Bacillus are also resistant to low pH, bile salts, and other adverse intestinal conditions,
which allows for higher concentrations of Bacillus to reach the gut (Barbosa et al., 2005;
Shivaramaiah et al., 2011). However, one of the major advantages of Bacillus species over other
probiotics is their ability to exclude pathogens through the production of antimicrobial peptides
(Stein, 2005; Santini et al., 2010; Shivaramaiah et al., 2011; Sumi et al., 2015).
Although the use of Bacillus based probiotics in feed has brought some benefits to
performance and gut health (Reis et al., 2017; Park et al., 2018), earlier delivery of these cultures
through in ovo inoculation may provide additional advantages that may obtain even earlier
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benefits. A single inoculated dose of a Bacillus probiotic has the potential to become established
in the embryo’s gut and create an unfavorable environment for any pathogenic bacteria that
could become hazardous to the chick’s health (De Oliveira et al., 2014). Similar to the effects
obtained when adding probiotics to the feed, early delivery of a probiotic could also promote
earlier stimulation of the immune system to confer some protection even before the chicks are
placed in a grow-out facility. Some studies that have evaluated other probiotic bacteria in ovo
have shown improvements in overall broiler health status and growth performance (Pender et al.,
2017).
In previous research trials by our team, Bacillus subtilis, as well as other probiotic
bacteria, were inoculated into the amnion of fertile eggs on day 18 of incubation. Different
concentrations of Bacillus subtilis such as 104 and 105 cfu/ 50µL reduced hatchability to less than
10%. Nonetheless, the other probiotic bacteria, such as Lactobacillus and Bifidobacterium, did
not show any reduction (Triplett et al., 2018). The high reduction in hatchability obtained from
the in ovo inoculation of B. subtilis is unexpected because this probiotic culture has been
previously shown to be advantageous for broiler health when included in the feed (Reis et al.,
2017; Park et al., 2018). The results of the previous study have limited the use of such an
advantageous probiotic culture through in ovo inoculation. Therefore, the objective of this study
was to evaluate different Bacillus subtilis serotypes to determine if they are also detrimental to
broiler hatchability. In the case that hatchability is not drastically reduced by the treatment’s
growth performance will be evaluated, as well as any modulations in ileum and ceca microflora
to determine the effectiveness of these cultures as beneficial bacteria.
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Materials and methods
Incubation
Fertile broiler eggs were purchased from a commercial source when the breeder
hens were approximately 55 weeks of age. Eggs were stored in a cooler at 18° C for three days
prior to setting. While in the cooler, all eggs that were dirty, cracked, or misshapen were
removed, and the remaining eggs were labeled according to egg number, flat and treatment. On
the day of setting, eggs were removed from the cooler and allowed to acclimate to room
temperature three hours prior to setting in the incubator to avoid moisture on the egg surface.
The incubators (Model NMC-1080, Jacksonville, FL, USA) were sanitized with 70% ethanol
prior to setting. For each treatment, 18 egg flats were randomly set throughout the two
incubators, and each treatment was represented on each level within the incubator. The dry and
wet bulb temperatures were set at 37.5°C ± 0.1 and 28.9°C ± 0.1, respectively. After 10 days of
incubation, eggs were candled to discard any eggs that were infertile, cracked, contaminated, or
presenting an early dead embryo. On day 18 of incubation, all remaining eggs were inoculated.
After in ovo injection, eggs belonging to each treatment were transferred into 18 previously
sanitized hatching baskets that were equally distributed among three Georgia Quail Farm®
hatcher units (3 hatcher x 4 treatments = 12 total GQF MFG, 1502 Digital Sportsman incubator;
Savannah, GA) until day 21 of incubation. The hatcher dry and wet bulb temperatures were set at
36.9°C ± 0.1 and 30°C ± 0.1, respectively. Sterile water was added each day at the same time, to
maintain the desired humidity level. Temperature and humidity data were recorded daily.
Treatments
The three B. subtilis evaluated in this study were obtained from ATCC. The bacterial
cultures were reconstituted as directed, and the obtained stocks were stored at -80°C. To
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determine the bacterial concentration of each bacterial culture, 1 mL was inoculated into 9 mL of
nutrient broth (BD Difco, Franklin Lanes, NJ) and incubated aerobically for 24 hat 37 °C
(VWR™ International, 1535 incubator, Cornelius, OR, USA). The 24 h culture was 10-fold
serially diluted and the dilutions were spread onto Mannitol Yolk Polymyxin B agar (MYP agar).
Plates were incubated aerobically at 37 °C for 24 h (VWR™ International, 1535 incubator,
Cornelius, OR, USA) and colonies present were counted, and log-transformed. The desired
concentration for in ovo injection was set to be approximately 106 cfu/50µL.
On the day of injection, a 24 h culture of each bacterial strain was diluted to obtain the
desired concentration for injection and centrifuged at 4,000 rpm for 5 min to obtain a pellet. The
supernatant was removed, and the pellet was reconstituted with sterile diluent. All treatments
were prepared on the day of injection and individually distributed into 800 mL bags of a
commercial sterile diluent. A standard HVT vaccine (16,000 doses/800 mL bag; Merial Select,
Inc., Gainesville, GA) was aseptically added with a syringe to each diluent bag. All diluent bags
containing each treatment were kept on ice until they were attached to the Inovoject® machine.
The applied treatments included: 1)50 µL HVT Marek’s disease vaccine and no probiotic (MV
alone), 2) Marek’s disease vaccine + B. subtilis spp. subtilis (ATCC 6051), 3) Marek’s disease
vaccine + B. subtilis spp. subtilis (ATCC 8473), 4) Marek’s disease vaccine + B. subtilis spp.
subtilis (ATCC 9466). During the in ovo injection, 50 µL were collected from each treatment
and spread onto the appropriate agar plates to confirm that the correct concentration of bacteria
was delivered for each treatment. Plates were counted after 24 h, and counts were logtransformed.
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Inoculation
After 18 days of incubation, egg flats for each treatment were removed from the
incubator, for injection. One egg from each flat was set aside for embryo staging, prior to
injection. One flat of developing eggs was inoculated at a time, and each needle, punctured the
egg at a depth of 2.49 cm to deliver each 50 µL dose automatically. Cleaning and sanitization
cycles were conducted between each treatment applied to avoid cross-contamination between
bacterial cultures. After each cleaning cycle, sterile water was flushed to remove any remaining
sanitizer from the injection line, and 50µL were collected and spread onto Tryptic Soy Agar
(TSA; Millipore Sigma, St. Louis, MO) plates to confirm that no bacterial contamination
occurred between treatments. After all treatments were inoculated, the eggs that had been
removed from each flat for embryo staging were in ovo inoculated with 50µL of a coomassie
blue dye and immediately euthanized via CO2 asphyxiation. Each embryo was analyzed to
confirm that the inoculated eggs were in the appropriate stage of development for 18 d of
incubation. Also, the presence of the dye surrounding the embryo’s body through the amniotic
fluid confirmed that the injection was correctly delivered into the amniotic fluid and did not
puncture the embryo’s tissue.
Hatch and grow-out
On d 21 of incubation, hatched chicks were counted and weighed to evaluate hatch of
fertile and average chick weight. Unhatched chicks were removed from their hatching baskets,
counted, and further evaluated to conduct a hatch residue analysis and determine the growth
stage of the embryo before its death. The egg number, treatment, and stage of each egg were
recorded as: early, mid, or late dead as well as pipped and contaminated eggs. Chicks and
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embryos were treated under the Guide for the Care and Uses of Agricultural Animals in
Research and Teaching (FASS, 2010).
Hatched chicks were feather sexed, and 100 males per treatment were moved to battery
cages, for a 21 d grow-out cycle. There were 10 cages for each treatment, which were set within
10 blocks throughout the house. Chicks were placed in cages where an empty cage was
represented on either side in an attempt to avoid cross-contamination between treatments. The
floor of each cage was covered with thin cardboard sheets, and each cage was equipped with 3
nipple drinkers and a single hanging feeder. From d0-7 of the grow-out, a tray was set in each
cage and feed was added daily. A regular corn and soybean meal diet was provided in two
feeding phases: starter diet from d0-14 and grower diet from d14-21 following Ross 708
guidelines (Ross 708 Nutrition Specifications, 2014). For the lightning schedule, a 23L: 1D
photoperiod was used from d1 to d7 and a 20L: 4D photoperiod was used from d8 to d21 in the
battery house. A commercial temperature program was followed as recommended by Aviagen
(“Ross Broiler Management Manual”, 2009).
Sampling and culture-based microbial analysis
On d0, 7, 14 and 21 of the grow-out, one bird from each cage was randomly selected,
humanely euthanized and necropsied to access their digestive tract. The ileum and cecum were
aseptically collected, weighed, and placed in sterile whirl-Pak (Nasco, Saugertis, NY) bags
which were kept on ice until further microbiological analysis. All tissues used for microbiology
were homogenized (Stomacher 400 circulator, Seward, Worthing, UK) with 1X Peptone
Buffered Saline at a 1:10 wt/vol (PBS, Fischer Scientific, Hampton, NH) and then serially
diluted with the same buffer. Out of the dilution tubes, 100 µL were spread onto Tryptic Soy
Agar (TSA, BD Difco, Franklin Lakes, NJ) and Eosin-Methylene Blue media (EMB, Oxoid,
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Thermo Fisher Scientific, Waltham, MA) to obtain total aerobic counts and total coliform counts,
respectively. The plates were incubated for 24 h at 37° C aerobically (VWR™ International,
1535 incubator, Cornelius, OR, USA), and counts obtained were log-transformed according to
BAM standards (Maturin and Peeler, 2001).
Statistical Analysis
All data collected were analyzed using SAS v. 9.4 (SAS Institute, Cary, NC). Hatch of
fertile and hatch residue data were analyzed using a completely randomized design where each
individual GQF hatcher served as the experimental unit (N=3). Growth performance parameters
such as BW gain, FCR, feed intake, as well as log coliform and log total aerobic counts were
analyzed using a randomized complete block design (10 blocks). Means were separated using
Fisher’s Protected LSD, and differences were considered significant when P ≤ 0.05 (Steel and
Torrie, 1980).
Results
In ovo inoculation and Bacillus concentration
Embryos obtained for embryo staging analysis on d18 of incubation were confirmed to be
in the right developmental stage, for in ovo inoculation. These embryos showed 3-lobed yolk
sacs, and their intestines were mostly enclosed within the abdominal cavity. Embryos inoculated
with Coomassie blue dye had dye surrounding their feathers and skin, which confirms that the
Inovoject® machine was correctly delivering the dose into the amnion, and not puncturing the
embryo’s body. Plate counts obtained for each treatment during in ovo injection resulted in the
following concentrations: T1 or MV alone: no bacterial growth, as expected; T2: 9.7 x 106 cfu of
B. subtilis ATCC 6051/50 µL; T3: 3.3 x 106 cfu of B. subtilis ATCC 8473/50 µL; and T4: 4.5 x
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106 cfu of B. subtilis ATCC 9466/50 µL. All treatments were administered at ̴ 106 cfu/50 µL,
which was the desired concentration. No growth was obtained on the TSA plates that were plated
after each cleaning cycle, which indicates that there was no cross-contamination between the
inoculated treatments.
Hatchability and growth performance
Hatch of transfer resulted in differences among treatments (Table 4.1). T2 reduced
hatchability to 17.3%. However, it was determined that other B. subtilis serotypes evaluated did
not have a negative impact on hatch of transfer, yielding hatch percentages higher than 94%,
which were not different compared to the MV alone treatment (P <0.0001). For hatch
performance, T2 resulted in an increased percentage of late dead as well as pipped embryos (P=
0.023 and P= <0.0001, respectively). Differences were also detected in average chick weight,
were T2 hatched chicks had a lower weight compared to the chicks from T1 T3 and T4
(P=0.0048).
Due to the drastically reduced hatchability induced by T2, there were not enough healthy
chicks to be placed in the grow-out facility, and the remaining chicks that did hatch were
euthanized humanely. Chicks from T1, T3, and T4 that were placed in the grow-out facility
showed no significant improvements in any growth parameter such as BW gain, feed intake, and
FCR on ant of the days evaluated (P>0.05, Table 4.2).
Culture-based bacterial analysis for ileum and ceca
Total aerobic bacteria count in the ileum resulted in significant differences among all
treatments evaluated (P= 0.0001). On the d of the hatch, total aerobic counts in the ileum were
reduced by T4, compared to MV alone and T2. By d7, T4 maintained the reduction of total
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aerobes compared only to the MV alone treatment. For the remaining days of the grow-out, no
further reductions in total aerobes were detected for any treatment (Figure 4.1).
Total coliform counts in the ileum also resulted in differences among treatments
(P=0.001). On d of the hatch, T4 reduced log coliform counts compared to the MV alone
treatment. On d7, no reduction in coliforms were detected according to treatment. As expected,
coliform counts increased for all treatments as the chick aged. However, on d14 both B. subtilis
treatments (T3 and T4) reduced coliform counts compared to the MV alone treatment. By d21,
neither of the B. subtilis treatments reduced coliform counts, on the contrary, T4 seemed to
induce an increase in coliform counts (Figure 4.1).
Total aerobic counts in the ceca also resulted in differences among all evaluated
treatments (P=0.0001). On the d of hatch, B. subtilis from both T3 and T4 reduced total aerobes
compared to the MV alone treatment. No further reduction in aerobic counts were seen for d7
and 14 of the grow-out by any of the treatment. However, by d21, aerobe counts seemed to be
reduced again in the chicks in ovo inoculated with B. subtilis from T4 (Figure 4.3).
Total coliform counts in the ceca also resulted in differences among treatments
(P=0.0001). No differences in coliform counts were detected on d of hatch or d14 of the growout. However, on d7 T4 seemed to reduce total coliforms compared only to the MV alone
treatment. By d21, T4 again caused a reduction of total coliforms compared to T3 and the MV
alone treatment (Figure 4.4).
Discussion
Hatchability and growth performance
The in ovo injection of different probiotic bacteria has been previously evaluated.
However, most of these studies lack applicability in industrial settings, due to the use of manual
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in ovo injection procedures, which are highly variable and depend on the expertise of the person
doing the inoculation. Besides this, the number of replicates falls short compared to regular trials
due to the intensive labor of injecting one egg at a time (Cox et al., 1992; Edens et al., 1997;
Meijerhof and Hulet, 1997; De Oliveira et al., 2014). For these reasons, interest has developed in
evaluating the in ovo administration of probiotics using an automated injection method such as
Inovoject® technology. This technology is an industry-standard for the delivery of vaccines
against Marek’s and infectious bursal disease (Johnston et al., 1993). This method has been
shown to increase the accuracy of injection to 83.8% compared to 36.1% obtained by manual
injection (Wakenell et al., 2002), and several flats of eggs can be inoculated over a short period
without impacting hatchability (Triplett et al., 2018; Beck et al., 2019)
Based on negative results obtained in hatchability due to the in ovo administration of B.
subtilis in a previous study by Triplett et al., (2018), there was an interest to determine if all
Bacillus subtilis serotypes have detrimental effects on broiler hatchability or if these effects are
serotype-specific for B. subtilis ATCC 6051. In the current study, differences among the
treatments were observed for percent hatch of transfer. Similar to the previous study by our
laboratory, B. subtilis from treatment 2 reduced hatchability to 17.3%. Likewise, a previous
study evaluating another serotype of B. subtilis (strain G7), demonstrated increased mortality in
fish and mice after delivering the bacterium intramuscularly (Gu et al., 2019). However, other B.
subtilis serotypes evaluated in the current study yielded hatch percentages higher than 94%,
which were not different to the MV alone treatment, in agreement with Da Silva et al., (2017),
who demonstrated no negative effects on hatchability when in ovo injecting a non-specified
Bacillus strain.
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The detrimental effect of B. subtilis ATCC 6052 from T2 was not expected because it has
been previously studied and determined to be safe for use as a probiotic. Previous work
demonstrated that it lacked hemolytic activity because the red blood cells on sheep blood agar
plates were not impacted by its presence (Dumitru et al., 2018). This strain is also Generally
Recognized as Safe (GRAS) by the FDA. Therefore, making it an attractive probiotic culture for
live trials (Kabisch et al., 2013). However, according to the results obtained in the current study,
this serotype is not safe for in ovo injection in broiler hatching eggs. One key characteristic of
this specific B. subtilis serotype (ATCC 6051), is the production of antimicrobial peptides as
well as amylase and protease enzymes (Dumitru et al., 2018). When added to feed, these
enzymes are known to improve nutrient availability and absorption, thus inducing improvements
in growth performance (Amerah et al., 2017; Alagawany et al. 2018). To our knowledge, there is
a gap in the research evaluating these enzymes and their effect on broiler embryos. However,
previous research in fish revealed that proteases play an important role in the mobilization and
hydrolysis of stored yolk proteins needed for embryonic development (Gwon et al., 2017). In
broiler embryos, it is well known that during the last stage of incubation, the yolk is the main
energy source used during the hatching process (Nangsuay et al., 2011; Şahan et al., 2014).
Although more research is needed to elucidate the exact causes, there is a possibility that the
enzymes produced by B. subtilis (T2) are somehow leading to reduced energy availability for
hatch, thus increasing the percentage of late dead and pipped embryos as seen in the current
study.
Similarly, hatchability was reduced considerably, as demonstrated by de Oliveira et al.,
(2014), who evaluated the manual in ovo injection of a non-specified Bacillus subtilis serotype.
Perhaps the strain evaluated was the same or of similar composition as B. subtilis from T2.
102

Nevertheless, the positive results obtained for B. subtilis from T3 and T4 are promising for the
use of these probiotic strains to promote further benefits in the chick’s life. Some benefits have
already been detected by Da Silva et al., (2017) who found that other Bacillus serotypes in ovo
can enhance broiler immune response to a Salmonella challenge. However, it is important to
emphasize that knowing not only the strain but also the serotype is relevant to obtain positive
results from the use of probiotics. This could be problematic since several studies describing the
use of certain probiotics refer only to the strain, which may be unreliable and could result in
detrimental effects as the ones obtained for B. subtilis ATCC 6051 in the current study.
Besides the drastically reduced hatchability, B. subtilis from T2 did not yield healthy
enough chicks to be placed in a grow-out facility. For the chicks from T1, T3 and T4 that were
placed, no difference in growth parameters were detected among the treatments on any of the
days evaluated. Our results agree with the results of another study, which evaluated the impact of
the manual ovo administration of a not-specified serotype of B. subtilis at a 107 cfu concentration
and found no changes in growth performance (Majidi-Mosleh et al., 2017). However, the
addition of different serotypes of B. subtilis in feed has previously shown reductions in FCR
(Reis et al., 2017) and increased BW gain (Gadde et al., 2017; Hayashi et al., 2018). The
improvements in growth performance obtained with the addition of B. subtilis in feed may be
due to the constant consumption of the probiotic, thus resulting in a higher B. subtilis
concentration available in the chicken’s gut throughout the grow-out period. Nonetheless, a
single in ovo dose of B. subtilis did not seem to be enough to result in changes in growth
performance. As previously mentioned, Bacillus has many advantages over other probiotic
strains, however in a vegetative state as delivered in the current experiment, it is not known to
persist in the chicken’s intestinal epithelium for long periods (Barbosa et al., 2005; Latorre et al.,
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2014). After the bird has hatched and began the process of digestion, the Bacillus dose delivered
may be transient in the chicken’s gut (Bernardeau, Lehtinen, Forssten, and Nurminen, 2017).
Thus, limiting the time available for Bacillus to exert its beneficial effects to approximately 6.5
hours as it passes through the gut (Latorre et al., 2014).
Bacterial analysis in ileum and ceca
Bacillus species have become of great interest for the industry due to their ability to
produce high quantities of enzymes and antimicrobial peptides (Abriouel, Franz, Omar, and
Galvez, 2011; Dumitru et al., 2018; Sumi et al., 2015). Bacillus species are also known to
modulate the environment in the chicken’s gastrointestinal tract and favor the growth of other
beneficial bacteria such as Lactobacillus (Hosoi et al., 2000; Jeong and Kim, 2014). An increase
in Lactobacillus culture in the gut in combination with the presence of Bacillus, could have great
implications for the reduction of unwanted infectious bacteria. In previous studies evaluating the
inclusion of non-specified serotype of B. subtilis in feed, reductions were obtained in S.
Typhimurium (Shivaramaiah et al., 2011), and Clostridium, which are two of the main pathogens
of concern in the poultry industry (Sen et al., 2012). In the current study, the presence of total
aerobic bacteria and total coliforms was quantified in the ileum and ceca, due to the high feed
retention time and large bacterial density present in these segments (Svihus, 2014). Total aerobe
counts were lowered by T4 in the ileum and by both T3 and T4 in the ceca on the day of hatch.
After this, on day 21 of the grow-out, T4 seemed to reduce total aerobes. A similar pattern was
detected for total coliforms, which were reduced by T4 in the ileum on the day of hatch. No
further modulations were detected until day 21 of the grow-out, were T4 seemed to reduce
coliforms in the ceca.
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Based on these results, it seems as if the inoculated B. subtilis dose was actively
modulating the chick’s microflora even days after it was delivered into the egg. However, its
effectiveness in modulating the bacterial profile in the ileum and ceca was lost after the first days
of hatch. It is important to emphasize that in this study, B. subtilis for all treatments were
inoculated as vegetative cells, and not as spores. Therefore, once the bird hatched, digestion and
gastrointestinal tract conditions may have reduced B. subtilis viable cell counts, and thus, their
effectiveness in promoting health benefits (Casula and Cutting, 2002; Barbosa et al., 2005;
Cartman et al., 2008). Bacillus counts recovered from this study, show a decrease in Bacillus
presence for all the chicks in ovo inoculated with Bacillus when compared to the MV alone
control (Data not shown). It may be possible that B. subtilis outcompetes naturally present
Bacillus in the chicken gut after the first weeks of hatch thus reducing their presence even
further. Prolonged benefits and even further improvements in microbial population, as well as in
growth performance, could be obtained by the injection of the same B. subtilis serotypes as
spores, given their ability to germinate and sporulate in a cycle in the gastrointestinal tract
(Casula and Cutting, 2002). However, the ability of a single in ovo probiotic dose even in a
vegetative form, to cause so many modulations in the microflora has great implications for
broiler management and a reduced incidence of infections.
The reduction in total aerobic counts and coliform detected on day of hatch was most
likely caused by B. subtilis’s production of antimicrobial peptides such as subtilin, subpeptin,
bacitracin, surfactin, bacisubin, among others (Stein, 2005; Sumi et al., 2015). These
antimicrobial peptides are known to be produced by Bacillus either ribosomally or nonribosomally, referring mostly to their antimicrobial range (Stein, 2005). Either way, these
antimicrobial peptides affect other bacteria through the disruption of their membranes, and not
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through the interruption of their different live processes, setting them apart from traditional
antibiotics used as growth promoters (Sumi et al., 2015). This main difference makes B. subtilis
a highly relevant probiotic bacteria, as it is hypothesized that other bacteria are less prone to
acquiring resistance to Bacillus produced antimicrobials, compared to the use of traditional
antimicrobials (Grant et al., 2018).
It is important to also emphasize some of the modulations in total aerobe and coliform
counts on day 21 of the grow-out, caused mainly by T4. As previously mentioned, the
persistence rate of Bacillus is not the strongest. Therefore, these modulations may not be caused
by the presence of Bacillus in the gut. At this stage of the chicken’s life (d21), these modulations
could be due to the maturation of the immune system, which is known to become most active
after week 3 of hatch (Nochi et al., 2018). However, if this were the case, aerobic and coliform
reductions would be caused by all evaluated B. subtilis treatments. Therefore, there is a
possibility that the early presence of B. subtilis, more specifically B. subtilis from T4 (ATCC
9466) in the chicken’s gut, had an early effect on the development of immune parameters that
somehow contributed to how bacteria were modulated on later days of the grow-out. However,
further research in cytokine modulations, antibody titers, spleen and bursa morphology, and bcell production need to be conducted to confirm these assumptions.
In conclusion, not all Bacillus species and serotypes are beneficial for broiler embryos,
even if the serotype has been previously claimed to be safe for use. However, other Bacillus
subtilis serotypes seem to be triggering early microflora modulations, which could have
beneficial effects for pathogenic reduction through-out the bird’s lifetime. There is a great
possibility for the occurrence of immune stimulations even with a single in ovo Bacillus subtilis
dose, which needs to be investigated further to determine its full potential for the control of
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infections. Further research evaluating the non-detrimental B. subtilis as spores and combining in
ovo with in feed applications are necessary to fully evaluate this probiotic and it's potential for
improving performance and overall broiler health.
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Tables
Table 4.1

Effect of in ovo injection of four individual B. subtilis serotypes at ̴ 106 cfu/ 50µL and a Marek’s vaccine alone control
on hatch parameters1.

MV
B. subtilis
B. subtilis
B. subtilis
alone
ATCC 6051 ATCC 8473 ATCC 9466
Hatch parameters
T1
T2
T3
T4
p-value
a
b
a
a
Hatch of transfer
94.7
17.3
96.1
96.2
<0.0001
Early dead embryos
0.45
0
0
0
0.0652
Mid dead embryos
0.58
0
0
0.21
0.1789
Late dead embryos
3.10b
12.4a
2.40b
2.30b
0.0023
b
a
b
b
Pipped embryos
1.15
69.5
1.32
0.85
<0.0001
Contaminated embryos
0
0.82
0.22
0.42
0.0628
a
b
a
a
Avg. Chick Weight (g)
44.1
42.2
43.6
43.2
0.0048
a-c
Means in a row not sharing a common superscript are different (P ≤ 0.005)
1
Observed means are calculated from 3 replicate values, using Each GQF hatcher as an experimental unit.
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SEM
1.215
0.118
0.188
1.401
0.551
0.182
0.374

Table 4.2

Live performance parameters of broilers in ovo inoculated with 3 different B. subtilis serotypes at ̴ 106 cfu/ 50µL and a
Marek’s vaccines alone control on d 18 of incubation, evaluated during a 21 d grow-out period1.
day of
growout

B. subtilis B. subtilis
B. subtilis
Performance
MV
6051
8473
9466
parameters
alone T1
T2*
T3
T4
p-value
SEM
BW gain (g)
0.111
0.109
0.108
0.836
0.0032
d 0-7
Feed intake (g)
0.121
0.129
0.119
0.686
0.0097
FCR
1.197
1.298
1.191
0.608
0.0904
BW gain (g)
0.189
0.187
0.187
0.980
0.0108
d 7-14 Feed intake (g)
0.243
0.260
0.256
0.645
0.0110
FCR
1.748
1.906
1.872
0.801
0.1517
BW gain (g)
0.446
0.470
0.466
0.517
0.0160
0.881
d 14-21 Feed intake (g)
0.573
0.564
0.559
0.0225
0.508
FCR
2.031
1.918
1.873
0.0904
BW gain (g)
0.746
0.770
0.761
0.619
0.0157
d 0-21 Feed intake (kg)
1.165
1.214
1.169
0.633
0.0408
0.786
FCR
1.681
1.719
1.658
0.0642
*
T2 reduced hatchability to 17.3%, therefore, no birds were placed in a grow-out facility
1
Observed means are calculated from 10 replicate values using each pen as the experimental unit (10 birds/cage; 100 total
birds/treatment).
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Figure 4.1

7

Days of grow-out
(T3) B. subtilis 8473

(T4) B. subtilis 9466

Treatment by day interactions observed for total coliform counts in the ileum of
broilers in ovo inoculated on d18 of incubation and evaluated during a 21 d growout.

The in ovo inoculated treatments are represented as follows: Marek’s vaccine alone
treatment is denoted by the dark gray bar. Treatment 3, B. subtilis ATCC 8473 is denoted by the
downward diagonal bar. Treatment 4, B. subtilis ATCC 9466 is denoted by the light gray bar.
Treatment 2 did not yield enough birds to move to a grow-out facility and sample, it is therefore
not represented in the figure. Total bacterial count in cfu/g is on the y-axis. The days of the
sampling during the grow-out are on the x-axis. Differences in mean bacterial count were
considered significant when the P- values were ≤ 0.05. Each bar has an error bar representing the
SEM. SEM= 0.429, P = <0.0001, and N=10 (10 cages/ treatment, 1 chick was randomly sampled
from each cage on each sampling day). Significant differences are distinguished according to
alphabetical superscripts, where means not sharing a common superscript are significantly
different.
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Figure 4.2
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Treatment by day interactions observed for total coliform counts in the ileum of
broilers in ovo inoculated on d18 of incubation and evaluated during a 21 d growout.

The in ovo inoculated treatments are represented as follows: Marek’s vaccine alone
treatment is denoted by the dark gray bar. Treatment 3, B. subtilis ATCC 8473 is denoted by the
downward diagonal bar. Treatment 4, B. subtilis ATCC 9466 is denoted by the light gray bar.
Treatment 2 did not yield enough birds to move to a grow-out facility and sample, it is therefore
not represented in the figure. Total bacterial counts in cfu/g are on the y-axis. The days of the
sampling during the grow-out are on the x-axis. Differences in mean bacterial count were
considered significant when the P values were ≤ 0.05. Error bars are representing the SEM.
SEM= 0.386, P = <0.0001, and N=10 (10 cages/ treatment, 1 chick was randomly sampled from
each cage on each sampling day). Significant differences are distinguished according to
alphabetical superscripts, where means not sharing a common superscript are significantly
different.
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Figure 4.3
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Treatment by day interactions observed for total aerobic counts in the ceca of
broilers in ovo inoculated on d18 of incubation and evaluated during a 21 d growout.

The in ovo inoculated treatments are represented as follows: Marek’s vaccine alone
treatment is denoted by the dark gray bar. Treatment 3, B. subtilis ATCC 8473 is denoted by the
downward diagonal bar. Treatment 4, B. subtilis ATCC 9466 is denoted by the light gray bar.
Treatment 2 did not yield enough birds to move to a grow-out facility and sample, it is therefore
not represented in the figure. Total bacterial counts in cfu/g are on the y-axis. The days of the
sampling during the grow-out are on the x-axis. Differences in mean bacterial count were
considered significant when the P values were ≤ 0.05. Error bars are representing the SEM.
SEM= 0.381, P = <0.0001, and N=10 (10 cages/ treatment, 1 chick was randomly sampled from
each cage on each sampling day). Significant differences are distinguished according to
alphabetical superscripts, where means not sharing a common superscript are significantly
different.
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Figure 4.4

7

Days of grow-out
(T3) B. subtilis 8473

14

21

(T4) B. subtilis 9466

Treatment by day interactions observed for total coliform counts in the ceca of
broilers in ovo inoculated on d18 of incubation and evaluated during a 21 d growout.

The in ovo inoculated treatments are represented as follows: Marek’s vaccine alone
treatment is denoted by the dark gray bar. Treatment 3, B. subtilis ATCC 8473 is denoted by the
downward diagonal bar. Treatment 4, B. subtilis ATCC 9466 is denoted by the light gray bar.
Treatment 2 did not yield enough birds to move to a grow-out facility and sample, it is therefore
not represented in the figure. Total bacterial counts in cfu/g are on the y-axis. The days of the
sampling during the grow-out are on the x-axis. Differences in mean bacterial count were
considered significant when the P values were ≤ 0.05. Error bars are representing the SEM.
SEM= 0.473, P = <0.0001, and N=10 (10 cages/ treatment, 1 chick was randomly sampled from
each cage on each sampling day). Significant differences are distinguished according to
alphabetical superscripts, where means not sharing a common superscript are significantly
different.
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CHAPTER V
IMPACT OF IN OVO INOCULATED LACTOBACILLUS SPECIES ON HATCHABILITY,
GROWTH PERFORMANCE, IMMUNE STATUS AND RESPONSE TO A COCCIDIOSIS
CHALLENGE
Abstract
Lactobacillus, a probiotic bacterium, modulates immune function in broilers when added
to their diet. An earlier administration of Lactobacillus could modulate immunity and alleviate
infection without affecting performance. The objective of this study was to determine if the
inoculation of different Lactobacillus strains into fertile broiler eggs impacts hatchability, growth
performance, and immune parameters. On d 18 of incubation, 4 in ovo treatments (T) were
applied: T1= Marek’s vaccine (MV) with no probiotic, T2= MV+ L. animalis, T3= MV+ L.
reuteri, T4= MV+ L. rhamnosus, all at ~106 cfu/50μl. At hatch, hatchability parameters were
evaluated, and 720 male broiler chicks (18/pen) were moved to a grow-out facility for a 42 d
grow-out (10 pens/T). A coccidiosis challenge was performed on d 14. On d 0, 14, 21, 28, and
42, BW and feed intake data were collected to evaluate growth performance. Spleen, bursa yolk,
and blood samples were obtained to evaluate bursa follicle area (BFA), white blood cell counts
(WBC), and cytokine levels (blood). No differences in hatchability, live performance
characteristics, lesion scores, spleen, bursa, and yolk weight were detected (P>0.05). T by d
interactions were detected for BFA, which increased on d 21 for T2 and T4 and d 28 and 42 for
T2 (P<0.001). Interactions were also seen for cytokine modulations where Pentraxin-3 levels
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were higher for T4 on d 14 and T3 on d 21 (P= 0.016). Compared to the control, d 0 IL-16 was
higher for T4, by d 14 it was reduced by all probiotic T, by d 28 it was reduced by T3, and by d
42 it was reduced by T3 and T4 (P=0.035). WBC were higher for all Lactobacillus T on d0.
Hatch and growth performance were not affected by the Lactobacillus inoculation. Immune
parameters were highly modulated by Lactobacillus, without impacting lesion presence in the
small intestine. Further research should determine how to enhance immune modulations, with
higher Lactobacillus doses or a multi-strain combination, as well as the inclusion of
Lactobacillus in a feeding stage, to provide additional protection against diseases.
Introduction
The U.S. poultry industry has been steadily growing over the past decade and currently
occupies one of the first places in chicken production (Windhorst, 2006; FAO, 2019). This trend
can be seen throughout the world due to the great demand for chicken products resulting from
the increasing human population (FAO, 2019). High broiler production rates and high stocking
densities have brought in new challenges, such as the effective control of pathogens present
during the grow-out (Abudabos et al., 2013; Tsiouris et al., 2015). In the poultry industry,
coccidiosis infections are regarded to result in severe economic losses due to reduced growth and
increased mortality (Kadykalo et al., 2018). Coccidiosis may be present at subclinical and
clinical levels with varying degrees of intestinal damage. The damage to the integrity of the
intestine is a predisposing factor to etiological agents ubiquitous in the broiler gut such as
Clostridium, Salmonella, and E. coli (Van Immerseel et al., 2004; Antunes et al., 2016; Rouger et
al., 2017). High concentrations of these agents are mainly responsible for major infectious
diseases such as necrotic enteritis (Moore, 2016; Williams, 2005), avian colibacillosis, and
salmonellosis (Kabir, 2010).
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For many decades, the use of antimicrobials at low doses successfully alleviated the
incidence of infections leading to improvements in growth promotion (Mehdi et al., 2018).
However, recent bans and consumer demands have led to antimicrobial free production (Singer
and Hofacre, 2006). Even though biosecurity measures and vaccination programs have improved
over the last few years, there is still a need to find other options that can positively contribute to
overall broiler health. Lactobacillus, along with other probiotic bacterium have been widely
evaluated as potential alternatives to antibiotics. Lactobacillus are Gram-positive, nonsporulating, lactic acid-producing, anaerobic bacteria (Claesson et al., 2007). These bacteria are
ubiquitous in the gastrointestinal tract of humans and animals at varying concentrations (Lebeer
et al., 2008). As a probiotic, some of Lactobacillus’s commonly known mechanisms of actions
include enhancing the function of the intestinal epithelial barrier, through its ability to adhere to
the gut; the inhibition of pathogens, and modulating microbe-microbe interactions; as well as
modulating immune responses. These mechanisms can vary within members of the Lactobacillus
family, each specie expressing their own set of mechanisms, and some can be linked between
species (Lebeer et al., 2008).
Lactobacillus are known to adhere to epithelial cells, intestinal mucus, extracellular
matrixes such as collagen, as well as in biofilms communities (Branda et al., 2005). The strong
adhesion ability of these bacteria makes them a desirable probiotic candidate given their long
persistence in the gut and the ability to exert other effects in the host. These beneficial effects
include outcompeting pathogens for nutrients, producing antimicrobial compounds, and
bacteriocins (Dec et al., 2018), as well as preventing the adherence of other pathogens in the gut
through competitive exclusion. Even though Lactobacillus is well known for its antagonistic
effect towards certain pathogens, they can also maintain synergistic activities with beneficial
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endogenous bacteria of the microbiome, and therefore promote their growth (Lebeer et al.,
2008). Previous studies have determined that the microbiome plays a fundamental role in
adaptive and innate immune response development and function (Brisbin et al., 2011; Cryan and
Dinan, 2012). There is also some indication that the microbiome and its composition may
influence the central nervous system and how the host responds to stress behaviors (Bravo et al.,
2011). Therefore, Lactobacillus’s ability to positively influence the microbiome, and its
commensal bacteria, may be a key function for the modulation of overall host immune status and
stress response (Bravo et al., 2011; Di Cerbo et al., 2016).
In poultry production, Lactobacillus has been extensively evaluated to determine its
beneficial effects in broilers. When administered as a feed additive or as a single dose through
oral gavage, different Lactobacillus strains have shown improve feed conversion ratio (De
Cesare et al., 2017; Fajardo et al., 2012; Forte et al., 2018; Khan et al., 2007) and increased body
weight gain (Salarmoini and Fooladi, 2011; Forte et al., 2018; Incharoen et al., 2019). However,
not all Lactobacillus results in improvements as determined by Cao et al., (2019), who showed
lower weight gain when including Lactobacillus in the diet. Certain Lactobacillus species
administered to poultry in the feed, have also been found to reduce infections in broilers by
reducing the presence of Campylobacter through cell membrane disruption (Neal-McKinney et
al., 2012). E. coli O78: K80 colonization has been reduced (Ding et al., 2019) and a C.
perfringens infection was suppressed through the single oral dose of Lactobacillus (La Ragione
et al., 2004). Some Lactobacillus species have also resulted in the reduction of lesions and oocyst
shedding during a coccidiosis challenge (Dalloul et al., 2005). However, as demonstrated by
Blajman et al., (2017), not all Lactobacillus species are able to reduce pathogens from the gut.
Besides these modulations, in feed inclusion of Lactobacillus can modulate the expression of
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different interleukins and regulate some Ig levels in the blood, which are related to an immune
response (Cao et al., 2019; Incharoen et al., 2019; Wu et al., 2019)
It has been previously established, that the immune system does not become fully
developed until two weeks after the chick hatches (Seto, 1981; Berghman, 2016). Therefore,
during the first weeks of age, broilers are more susceptible to infections, affecting their
performance throughout the entire grow-out period (Swaggerty et al., 2019). Therefore, it is
believed that an earlier administration of Lactobacillus could modulate the microbiota and result
in earlier modulation of the broilers immune system. However, in order to avoid the intensive
labor involved in oral gavaging thousands of birds in a grow-out house, in ovo inoculation could
be utilized to automatically administer a single probiotic dose before the embryo hatches. Thus,
the objective of this study was to evaluate the automated in ovo inoculation of three different
Lactobacillus strains to determine their influence in broiler histo-immunological parameters
through a 42 d grow-out period. Most importantly, this study will determine if any immune
modulations obtained are enough to suppress a coccidiosis challenge without impacting growth
performance parameters.
Materials and methods
Treatment preparation
The three Lactobacillus strains utilized in this study were obtained from ATCC. The
cultures were in freeze-dried form and reconstituted as instructed by ATCC. Frozen stocks of the
live culture in glycerol were stored at -80 °C in 1 mL aliquots. The concentration of each
Lactobacillus culture was evaluated by inoculating 1 mL of the culture into 9mL of MRS broth
(BD Difco, Franklin Lakes, NJ). The culture was incubated anaerobically (Spiral Biotech
Anoxomat; Norwood, MA) for 48 h at 37 °C (VWR™ International, 1535 incubator, Cornelius,
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OR, USA). The culture was serially diluted by 10-fold in Peptone Buffered Saline (PBS,
Millipore Sigma; Burlington, MA), and aseptically spread onto sterile MRS agar plates (BD
Difco, Franklin Lakes, NJ). Plates were incubated anaerobically for 48 h at 37 °C. Colonies
present ranging from 30-300 were counted and log transformed.
The desired concentration of Lactobacillus for inoculation was approximately 106
cfu/50µL inoculation per egg. To prepare each treatment, the Lactobacillus cultures were
cultured individually 48 h prior to inoculation. On the day of inoculation, the cultures were
centrifuged at 4, 000 rpm for 10 minutes to obtain a pellet. The supernatant was removed, and
the pellet was reconstituted with 5 mL of sterile diluent. Each reconstituted culture was
distributed into 800 mL bags of a commercial Marek’s disease vaccine diluent, used as the
carrier for the delivery of each dose into the egg. For all treatments, a standard HVT vaccine
against Marek’s disease (16,000 doses/800 mL bag; Merial Select, Inc., Gainesville, GA) was
aseptically added into each diluent bag (1 bag/ treatment). All diluent bags were kept on ice until
their use in the Inovoject® machine. The treatments applied included: 1) 50 µL of a Marek’s
disease vaccine (HVT vaccine) with no probiotic (MV alone), 2) Marek’s disease vaccine + L.
animalis (ATCC 35046), 3) Marek’s disease vaccines + Lactobacillus reuteri (ATCC 2837), 4)
Marek’s disease vaccine + L. rhamnosus (ATCC 23272). During the in ovo inoculation
procedure, 50 µL from each treatment were collected and spread onto the appropriate agar plates
to confirm that expected concentration of each Lactobacillus species was delivered in each
inoculation. Plates were incubated anaerobically for 48 h at 37° C, and the colonies obtained
were counted and log transformed.
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Egg incubation and inoculation
Fertile broiler eggs originating from hens at peak production were obtained from a
commercial source and stored in an 18° C set cooler. Three days after storage, eggs were brought
to room temperature prior to setting in the incubator to avoid moisture on the egg surface. Eggs
were given a number and labeled according to flat and treatment to be applied. Before setting,
incubators were sanitized with 70% ethanol. Two Natureform incubators were used for the
current experiment (Model NMC-1080, Jacksonville, FL, USA), randomly setting 18 egg flats in
each, with a total of 1,080 eggs set. Dry and wet bulb temperatures were set at 37.5°C ± 0.1 and
28.9°C ± 0.1, respectively. After 12 d of incubation, eggs were candled to discard eggs that
presented infertile, cracked, contaminated, or early dead embryos.
On d 18 of incubation, cleaning and sanitization cycles were run through the commercial
Inovoject equipment (Zoetis, Parsippany, NJ) before the inoculation procedure. All flats
belonging to the same treatment were removed from the incubator, and one egg from each flat
was removed for embryo staging. One flat of eggs was inoculated at a time, and each egg was
automatically punctured with a 2.49 cm long needle that delivered the 50 µL dose. After all flats
from each treatment were inoculated, cleaning and sanitization cycles were run to prevent crosscontamination. After each sanitization step, sterile water was flushed through the equipment to
remove any remaining sanitizer that may affect the probiotic counts. Microbial samples were
collected and spread onto Tryptic Soy Agar (TSA; Millipore Sigma, St. Louis, MO) plates to
confirm that no bacterial contamination occurred between treatments. The eggs previously
selected for embryo staging were inoculated with 50µL dose of Coomaassie blue dye (Thermo
Fisher Scientific, Waltham, MA) and immediately euthanized via CO2 asphyxiation. Embryos
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were evaluated to determine their development stage. The Coomassie blue dye was used to
indicate the location of the in ovo inoculation within the egg.
After in ovo inoculation, eggs belonging to each treatment were transferred into
previously sanitized hatching baskets (18 baskets/ treatment, 6 baskets/ hatcher) distributed
among three Georgia Quail Farm® hatcher units (3 for each treatment, 12 total GQF MFG, 1502
Digital Sportsman incubator; Savannah, GA) until day 21 of incubation (day of hatch). The
hatcher’s dry and wet bulb temperatures were set at 36.9°C ± 0.1 and 30°C ± 0.1, respectively.
Sterile water was added each day at the same time, to maintain the desired humidity level.
Temperature and humidity logs were supervised daily.
Hatching day
On d 21 of hatch, hatched chicks were removed according to treatment to avoid crosscontamination. Hatched chicks were counted, weighed and feather sexed according to the Ross
Broiler management manual (2009). Male chicks were transferred to a grow-out facility,
distributing 18 chicks per pen (10 pens/ treatment) at a 0.20 m2/chick stocking density. In the
grow-out facility, blocks were arranged so that chicks were placed every other pen, to avoid
cross-contamination. Unhatched eggs were counted and evaluated through a hatch residue
analysis to classify as early dead, mid dead, late dead, infertile, contaminated, or cracked
according to Aviagen break-out guidelines (“How to… Break Out and Analyse Hatch Debris,”
2017).
Grow-out and sampling days
Hatched chicks were transferred to the grow-out facility for a 42-day period. The house
was equipped with three nipple drinkers per pen and a feeder. Windrowed litter from a
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commercial house and wood shavings were utilized to cover the floor. The four different
treatments were randomly distributed within blocks in the house (10 blocks). For the lightning
schedule, a 23L: 1D photoperiod was provided from d 1 to d 7 and a 20L: 4D photoperiod was
provided from d 8 to d 42 in the house. A commercial temperature program was followed as
recommended by Aviagen. An industry-standard basal diet, according to Ross 708 Nutrient
Guidelines, was provided in crumble form to birds in the starter (d 0-14) phase. A pellet diet was
provided for the grower (d 14-27) and finisher phase (d 28-42). All diets consisted of corn,
soybean meal and poultry fat based on Ross 708 guidelines and did not contain antibiotics or
anticoccidials (“Ross 708 Nutrition Specifications”, 2014). Feed and water were supplied ad
libitum. On day 14 of the grow-out, a coccidiosis challenge was conducted through oral gavage
to induce stress on the chicks. A 20X dosage of Coccivac®-B52 (Intervet Inc., Omaha, NE)
consisting of five Eimeria species in live oocyst form (E. acervulina, E. maxima E. maxima
MFP, E. mivati, and E. tenella) was administered.
On day 0, 14, 28, and 42 of the grow-out, chicks and feed were weighed to evaluated
growth performance characteristics. Mortality number and weight was recorded daily. On these
days, one chick from each pen was randomly selected to collect and record spleen, bursa, and
yolk weights (10 chicks/treatment). Bursa tissue and blood were collected for further analyses
described below. On d 21 and 28, small intestinal tissues were evaluated for lesions. In this
experimental trial, all animals were treated in compliance with the Guide for the Care and Uses
of Agriculture Animals in Research and Teaching (Federation of Animal Science Societies,
2010) and the Mississippi State University Institutional Animal Care and Use Committee
(IACUC Animal Welfare Assurance #A3160-01).
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Immuno-histological analyses
Bursa
Bursas were collected and preserved in 10% formalin to evaluate the bursa follicle area.
For analysis, a 0.3 cm section of the bursa was dissected along its sagittal plane and fixed in a
Unisette™ Biopsy Cassette (Ted Pella, Inc., Redding, CA). Mississippi State University College
of Veterinary Medicine Diagnostic Lab, prepared the sectioning, fixing onto a microscope glass
slide and staining with hematoxylin and eosin. The fixed glass slides were then observed under a
microscope at a 4X magnification, to measure bursa follicle area (μm2) using the Infinity
Analyze System (Microscope World, Carlsbad, CA). For each slide representing the bursa from
one chick, three follicles within each fold were randomly evaluated (3-fold/ bursa; 9 total
measurements).
Blood analysis
Blood was collected from the wing using a 21-gauge needle and 3 mL syringe. Blood
collected was used to analyze total white blood cell counts (WBC) and quantify chicken
cytokines.
For WBC analysis, a small drop of freshly collected blood was smeared onto a glass slide
and set to dry. The slides were immersed in ethanol and stained using Wright Stain (Wright Stain
procedure No. WS; Sigma-Aldrich, Inc., St. Louis, MO) and left to dry separately. The slides
were then observed under a microscope at 40X magnification to detect and count heterophils,
lymphocytes, and total white blood cell counts based on the morphological criteria established by
Lucas and Jamroz (1961). For each slide representing the sample from one chick, 10 frames were
evaluated. (10 chicks/ treatment, 40 slides total).
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The rest of the blood was collected in glass tubes (BD vacutainer; Franklin Lanes, NJ) for
cytokine quantification. The tubes were kept on ice and later centrifuged at 2,500 rpm for 15
minutes to separate the serum from the red blood cells (Centrifuge 5810R, Eppendorf; Hamburg,
Germany). The serum was collected and stored at °-20C until further analysis. Samples were
analyzed using Quantibody Chicken Cytokine Array Q1 (RayBiotech Life, Norcross, GA)
following the manufacturer’s instructions. The microarray slides obtained were visualized with a
ScanArray Express Microarray scanner at 100 Power and 750 PMT (PerkinElmer, Inc.,
Waltham, MA) to acquire images. Images were analyzed using the Spotxel program (Sicasys
Software GmbH, Heidelberg, Germany) to obtain fluorescence intensity measurements. The data
obtained was normalized and analyzed using the Cytokine QAG-CYT-1 Q-Analyzer v8.10.4
(RayBiotech Life, Norcross, GA).
Statistical analysis
All data collected were statistically analyzed using SAS v. 9.4 (SAS Institute, Cary, NC).
Data for hatch of fertile and hatch residue were analyzed using a completely randomized design.
Each GQF hatcher served as an experimental unit, with 3 hatchers per treatment (N=3). Live
performance data were analyzed using a randomized complete block design, where blocks served
as the replicate unit (10 blocks). Bursa follicle area, WBC counts, and the cytokine
quantifications were analyzed using a Randomized complete block design, where block
represented the replicate unit (5 blocks). Lesion scores were calculated as percentages for each
tissue of the small intestine. Means were separated using Fisher’s Protected LSD, and differences
were considered significant when P ≤ 0.05 (Steel and Torrie, 1980).
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Results
Inoculation procedure and Lactobacillus concentration
Embryo staging analysis on the day of inoculation confirmed that the eggs inoculated
were in the appropriate developmental stage as expected for d 18 of incubation. These embryos
showed intestines that were mostly enclosed within the abdominal cavity and the yolk displayed
three exposed lobes. The Coomassie blue dye covered the embryo, meaning that it was
effectively delivered into the amnion, and did not puncture the embryo’s body tissue. To confirm
the concentration of bacteria inoculated, MRS plates spread on day 18 of incubation resulted in
the following concentrations: T1 a Marek’s disease vaccine alone (HVT vaccine; MV alone) as a
control: no bacterial growth as expected; T2 (L. animalis ATCC 35046): 7.1 x 106 cfu/50µL; T3
(L. reuteri ATCC 2837): 3.7 x 106 cfu/50µL; and T4 (L. rhamnosus ATCC 23272): 5.9 x 106
cfu/50µL. All Lactobacillus treatments were at approximately 106 cfu/50µL as desired. To
confirm the effectiveness for the cleaning and sanitizing cycles in between each treatment
application, TSA plates showed no bacterial growth, proving that no cross-contamination
occurred during the inoculation process.
Hatchability and growth performance
For hatch, no differences were detected on hatch of transfer among any treatments (P=
0.56). Percent hatch of transfer was higher than 93% for all in ovo inoculated treatments. No
differences were detected on mid dead, late dead, pipped, contaminated, or culled embryos (P>
0.05). A trend was detected on average chick weigh, were T2 yielded numerically lighter chicks
compared to MV alone, T3, and T4 (P=0.08). The average weight for each flat of eggs was not
different among treatments (P=0.33) (Table 5.1).
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For growth performance, no differences were detected for live weight gain, feed intake,
or FCR at any stage of the grow-out, for any treatment (Table 5.2). However, from d 28 to 42 a
trend was detected, were FI was numerically lower for MV alone and T2 compared to T3 and T4
(P= 0.092).
Lesion scores and tissue weight
No differences were detected in yolk weight during the days evaluated (P=0.921). The
spleen and bursa weight relative to body weight showed no differences according to treatment
(P= 0.102 and P=0.408, respectively; Table 5.3). Lesion score data were not different among
treatments for any day of the grow-out (data not shown, P> 0.005). However, to confirm the
presence of a challenge, the percentage of positive lesions present in each segment of the small
intestine is presented in Table 5.4. More than 80% of the birds evaluated presenting lesions in
the duodenum. However, a higher incidence was seen in the jejunum, where more than 85% of
the birds evaluated presented lesions. The number of birds presenting lesions in the ileum
diminished to less than 55% and less than 20% in the ceca.
Immuno-histological analyses
Bursa follicle area
A treatment by day interaction was detected for average bursa follicle area (BFA)
(Figure 5.1). On d 0 and 14 of the grow-out, no differences were detected among treatments. On
d 21, T2 and T4 had higher average BFA when compared to the MV alone treatment. By d 28,
T3 had an increase in average BFA, whereas T2 and T4 were reduced but not lower compared to
MV alone. The increase caused by T3 persisted through d 42 of the grow-out.
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Heterophil- lymphocyte ratio
A treatment by day interaction was detected in heterophil – lymphocyte ratio (H: L) (P=
0.0138; Figure 5.2). Modulations are seen starting on d 0 of the grow-out, where all
Lactobacillus treatments had significantly higher H: L ratio compared to the MV alone
treatment. By d 14, almost all differences were lost, except for T2, who maintained a higher H:
L. By d 21, the H: L for T2 was found to be similar to T3 and the MV alone treatment; however,
the H: L for T4 was found to increase. No further differences were seen for d 28 or d42 of the
grow-out.
Cytokine quantification
The chicken cytokine array kit used detected and quantified the presence of 10 chicken
cytokines: Caronte, IFN-gamma, IL-16, IL-10, IL-12p40, IL-16, IL-21, Netrin-2, Pentraxin 3,
and Rantes. Treatment by day interactions were detected for IL-16, Pentraxin 3 and a trend was
detected for IL12-p40.
IL-16 was highly modulated through the entire grow-out period (Figure 5.3). On d 0, T4
resulted in a higher IL-16 expression compared to T3 but resulted in no differences compared to
the MV alone treatment and T2. By d 14, T2 and T3 resulted in reduced expression of IL-16,
compared to the MV alone treatment. However, T4 was not different. By d 21, IL-16 seemed to
be lower when compared to the other days of the grow-out, but no differences among treatments
were detected. By d 28 of the grow-out, IL-16 was lower for all Lactobacillus treatments
compared to the MV alone treatment. The decrease in IL-16 was maintained on d 42 for T3 only,
while T2 and T4 were not found to be different than the MV alone treatment.
Treatment by day interactions were also detected for Pentraxin3 (P=0.0159) (Figure 5.4).
On d 0, T3 and T4 had reduced Pentraxin3 levels compared to MV alone treatment and T1.
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Pentraxin3 levels were numerically higher for T2 when compared to the control, and
significantly higher compared to T3 and T4. By d 14, T2 reduced Pentraxin3 levels compared to
d 0. However, T4 caused a significant increase in Pentraxin3. By d 21 most of these differences
were lost. However, T3 expressed higher pentraxin3 levels compared to the other treatments. On
d 28 and 42, no differences were detected among treatments.
A trend was detected for IL12p40 for day and treatment effects (P= 0.059; Figure 5.5).
On d 0 of the grow-out, T2 caused an increase in IL12p40 expression compared to the other
treatments. The difference obtained during d 0 were lost for d 14 and d 21 of the grow-out. By d
28, T2 increased IL12-p40 levels compared the rest of the treatments. However, these differences
were lost for all treatment on d 42.
Discussion
Hatch performance
Probiotics have been previously suggested as alternatives to antibiotics (Koenen et al.,
2002; Edens, 2003; Alagawany et al., 2018). Different Lactobacillus species such as L.
acidophilus, L. salivarius, L. reuteri, L. rhamnosus, as well as L. plantarum are some of the most
prominent members of the intestinal microbiota of chickens (Wang et al., 2014). These species
and other serotypes within these species have been widely evaluated as a probiotic feed additive
and through oral gavage. Although different results have been obtained according to the specific
serotype evaluated, the oral administration of Lactobacillus resulted in an overall improved
broiler health status (Khan et al., 2007; Salarmoini and Fooladi, 2011; Fajardo et al., 2012; De
Cesare et al., 2017; Forte et al., 2018; Incharoen et al., 2019). However, the earlier
administration of probiotics still needs to be evaluated to determine if the same benefits can be
obtained through a single probiotic dose.
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The in ovo inoculation of Lactobacillus, more specifically L. reuteri, was first evaluated
in the late 90’s demonstrating that manually injecting the eggs with a probiotic, resulted in
hatchability of 60% (Edens et al., 1997). Similarly, the inoculation of an undefined competitive
exclusion culture into the amnion, drastically reduced hatchability to 0%, when not- diluted and
to 40% when diluted 6 folds (Cox et al., 1992). De Oliveira, et al., (2014) evaluated the manual
inoculation of several probiotic cultures such as different Bacillus species, Enterococcus
faecium, and a combination of Lactobacillus serotypes which resulted in hatchability of less than
70%, and single Lactobacillus species which resulted in hatchability at non-detectable levels. By
2017, there was an automatic in ovo injection method utilized for the delivery of a multi-strain
probiotic mixture containing 21 different serotypes of Lactobacillus, Bacillus and Pediococcus,
which resulted in hatchability of 86.3% (Teague et al., 2017). Other studies evaluating
commercial Inovoject technology, demonstrated that this method of probiotic delivery does not
impact hatchability. However, a previous study determined that different probiotic bacteria could
affect embryos differently. The in ovo inoculation of L. acidophilus resulted in hatchability
levels that were higher than 90%; meanwhile, B. subtilis reduced hatchability to less than 40%
(Triplett et al., 2018).
In the current study, a commercial Inovoject® technology was utilized to deliver a single
dose of each treatment into the amnion. L. animalis, L. reuteri, and L. rhamnosus at a 106
cfu/50µL resulted in hatch of transfer levels higher than 92%. None of the Lactobacillus
evaluated had detrimental effects to the embryos as compared to other probiotic cultures
inoculated in ovo (Triplett et al., 2018; Castañeda et al., 2018). These results agree with previous
research evaluating a similar strain as the one in this study, L. animalis alone or in combination
with E. faecium (Beck et al., 2019). No differences were detected in mid dead, late dead, pipped
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or contaminated embryos for any of the treatments evaluated. However, a trend demonstrated
that T4 resulted in a numerical increase in average chick weight compared to the other
treatments. Hatchling weight has been said to be influenced by egg weight (Traldi et al., 2011);
however, in this study, no differences were detected in average egg weight before setting.
Therefore, the numerical increase in hatchling weight could be due to improved use of available
nutrients. It has been previously shown that other probiotic bacteria such as E. faecium
influenced the rate of yolk consumption before hatch, possibly resulting in differences detected
in intestinal morphology (Castañeda et al., 2018). However, no differences were detected in yolk
weight in the current study, probably leading to numerical and not significant differences in
average chick weight. Overall, compared to earlier studies evaluating manual in ovo inoculation
of Lactobacillus (Cox et al., 1992; Edens et al., 1997) and oral gavage methods, the use of
commercial in ovo technology is an efficient non-detrimental method for the combined delivery
of vaccines and probiotics in a single dose.
Growth performance and intestinal lesions
In the current study, a coccidiosis challenge with a 20X dose of B52 Coccivac was
carried out and the presence of lesions was observed in the different segments of the small
intestine. As expected, lesions were present seven days after the challenge (Edgar, 2007). As
previously established (Edgar, 2007), the high percentage of lesions detected in the duodenum
are possibly caused by E. acervulina. The highest percentage of lesions was detected in the
jejunum, possibly caused by the two types of E. maxima (E. maxima and E. maxima MFP)
present in the vaccine which further intensified the infection. The ileum and ceca had lower
percentages of lesion presence, possibly from E. maxima’s transitioning to the rest of the
intestine, and in the cecum caused by E. tenella (Raman et al., 2011).
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The inclusion of commercially available Lactobacillus based product in broiler diets has
been extensively studied as a method to mitigate the effects of coccidial infection. In feed
applications Lactobacillus seemed to reduce Eimeria oocyst shedding and confer higher
protection against intestinal lesions (Dalloul et al., 2005; Lee et al., 2007; Awais et al., 2019).
The oral gavage of a coccidiosis vaccine combined with a commercial probiotic on day of hatch
reduced lesion presence in the duodenum (Ritzi et al., 2016). In the current study, no differences
in intestinal lesions scores were detected among the evaluated treatments. Also, growth
performance parameters were not affected by the coccidiosis challenge nor by any of the
Lactobacillus treatments. These results agree with Beck et al., (2019) who showed no effects on
growth performance characteristics with the in ovo inoculation of L. animalis alone or in
combination with E. faecium. Similarly, Pender et al., 2019 evaluated the in ovo administration
of a multi-strain probiotic. In their study, no improvements in growth performance were
observed under challenged conditions. However, improvements were seen under non-challenged
conditions. It is important to emphasize that in the current study, all treatments, including the
MV alone treatment, were subjected to a coccidiosis challenge, which could explain the lack of
differences were seen in performance. Nevertheless, the absence of difference in growth
performance among MV alone and the different Lactobacillus treatments demonstrate that in the
ovo inoculation of probiotics is not detrimental for broiler growth. This implicates that the
delivery of Lactobacillus into the egg can be further evaluated, to discover how to obtain their
maximum benefits for the improvement of overall broiler health status.
Analysis of immune parameters
Naturally, the presence of Lactobacillus in the chicken’s gastrointestinal tract has been
detected after one week of hatch (Mead et al., 1999). Through the in ovo inoculation of
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Lactobacillus into the amnion, the probiotic is expected to be present in the embryo’s
gastrointestinal tract on d 18 of inoculation, as previously demonstrated for other bacteria
through the use of bioluminescent imaging for bacterial detection (Castañeda et al., 2019). It is
believed that an earlier probiotic inoculation could allow Lactobacillus to become a protective
layer surrounding the gut, eliciting beneficial responses, and protection against infectious agents.
Most importantly result in an early stimulation of the immune response in broilers (Lebeer et al.,
2008).
Immune response
The immune system and its functions are complex and have been previously
characterized in detail (Erf, 2004; Júnior et al., 2018). There are two main components of the
avian immune system, the innate and the acquired immune response. The innate immunity is a
quick response mechanism, and it is the initial line of defense against foreign material. Cells
such as macrophages, dendritic cells, heterophils, and lymphocytes detect antigens such as
bacteria, viruses, or parasites present in the chick’s body through toll-like receptors. These cells
can phagocytose the antigen while the complement system elicits a series of reactions to prevent
further infection (Júnior et al., 2019).
The acquired immune response begins after the innate response sends signals indicating
that an antigen is present, and it is, therefore, more delayed. Different pathways can take place
depending on the type of antigen detected, either extracellular (bacterial) or intracellular (viral),
through the detection of different antigen peptides. These peptides bind to Major
Histocompatibility Complex (MHC), which presents the antigen to lymphocytes such as the Tcells (Erf, 2004; Chaplin, 2010; Junior et al., 2018). There are different types of T-cells
depending on the types of antigen and, therefore, their function. T helper cells (th cells) produce
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proteins known as cytokines, which signals the initiation of acquired immune response from bcells (Erf, 2004). B-cells are produced in the bursa and they play an important role in producing
highly specific antibodies against antigens (Junior et al., 2018). Through the b-cell specificity for
antigen production, the immune system develops an immune memory allowing protection
against future infections (Takahashi, 1967). In the current study, immune parameters were
evaluated for innate immunity through the heterophil-lymphocyte ratio, at the intermediary
signaling stage through spleen weight and cytokine modulation, and at the acquired response
level through modulations in bursa weight and bursa follicular area (BFA).
Heterophil and Lymphocyte ratio (H: L ratio)
Heterophils are phagocytic leukocytes present in birds, easily distinguished from other
cells through the granules in their structure (Juul-Madsen et al., 2014). Maxwell and Robertson,
(1998) claimed that chicken heterophils had been previously considered as “the window to their
state of health”, demonstrating the body’s response to infections and different stressors.
Heterophils as well as other white blood cells are part of the innate response, and can detect and
phagocytose antigens present (Harmon, 1998). Therefore, under the presence of an antigen or
other stimuli, it is common to observe an increase in heterophils in the blood (Scanes, 2016).
High heterophils numbers are released by the spleen at hatch, due to the process of bone marrow
maturation. Therefore, higher heterophil counts are expected on the first days after hatch, and a
12% decrease in counts seven days after hatch (Maxwell et al., 1998; Zulkifli and Siegel, 1993).
In the current study, high H: L ratios were seen on day of hatch compared to the rest of the days
of the grow-out. However, on this same day, all the Lactobacillus treatments resulted in higher
H: L ratios compared to the MV alone treatment, and T2 was able to maintain high levels until
day 14. These findings agree with (Stefaniak et al., 2019), who demonstrated higher H: L ratio
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with the in ovo administration of prebiotics and synbiotics containing different Lactobacillus
strains combined with a prebiotic. The in ovo inoculation of the Lactobacillus strains in the
current study, can, therefore, be considered an early stimulus to enhance leukocyte development
and maturation (Stefaniak et al., 2019).
The H: L ratio has been widely used as an indicator of stress levels in broilers and hens.
The ratio is known to increase under stressful conditions such as high stocking density, elevated
temperatures, and infections due to the increase in corticosterone levels (Gross and Siegel, 1983).
Previous research has shown that the addition of probiotics can reduce the H: L ratio of hens
under normal and stressful conditions (Khan et al., 2011; Tang et al., 2017). In the current study,
the H: L ratio was expected to be severely modulated by day 21 and 28, due to the coccidiosis
challenge. However, from day 21 to 28 no differences were detected between the Lactobacillus
and the MV alone treatment. The H: L ratio for the remaining days of the grow-out ranged
between 0.4 and 0.6. On day 21, T4 seemed to have an increase in H: L ratio compared only to
T2. Nevertheless, this modulation did not result in any differences that could indicate any stress
alleviation by any of the Lactobacillus treatments. Another study evaluating the effect of some
feed additives in challenged and unchallenged chicks, obtained H: L ratios of 0.65 in
unchallenged chicks and 1.40 in challenged chicks (Moraes et al., 2019). The differences in H: L
ratio compared to Moraes et al., (2019) may indicate that the severity of the coccidiosis
challenge in the current study may not have been strong enough to cause significant modulations
in H: L ratios.
Spleen weight and Cytokine modulation
The spleen is a secondary lymphoid organ, and during embryonic development, it
functions as a hematopoietic organ (Cooper et al., 2004; Zhang et al., 2019). T cells produced in
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the thymus emigrate and colonize the spleen were they mature into their different types (Sharma
and Tizard, 2007). As previously mentioned, some t-cells such as the th cells can produce
cytokines which play an important role as messengers that signals the initiation of the adaptive
immune response. Previous studies correlated the immune competence of the spleen to their
weight relative to body weight (Kabir et al., 2004; Slawinska et al., 2014). In the current study no
differences were detected in spleen weight according to any of the treatments. Nevertheless,
some cytokines were modulated in the current study.
Cytokines are classified according to their functions in modulating immunity and can be
expressed differently according to the type of antigen present (Brisbin et al., 2008; Kogut, 2000).
On a broad scale, there are pro-inflammatory cytokines, anti-inflammatory cytokines,
interferons, chemokines, and a wide variety of cytokines produced by the different T helper
lymphocytes (Kogut, 2000; Wigley and Kaiser, 2003). In a previous in vitro study utilizing
spleen and cecal cells, it was demonstrated that different cytokine profiles can be obtained in the
presence of different types of probiotic cultures. L. acidophilus seems to increase the expression
of Th1 related cytokines such as IL-12p40, IL-18, IL-1B, and IFN- γ. L. reuteri, also induced IL12p40 expression but reduced IFN-γ gamma levels (Brisbin et al., 2010). However, L. salivarius
had opposite results compared to the other Lactobacillus strains, with no increase in IL-12p40, or
IFN-γ, therefore, L. salivarius mechanisms of action are based on their lack of pro-inflammatory
cytokines (Brisbin et al., 2010). These differences in cytokine modulation were confirmed in a
later study evaluating the effect of weekly Lactobacillus oral gavage in broiler immune response
(Brisbin et al., 2011).
In the current study, it was also determined that only some Lactobacillus elicit certain
responses. Only L. animalis increased the inflammatory cytokine IL-12p40 on the day of hatch
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and 14 days after the coccidiosis challenge, as expected after an Eimeria infection (Hong et al.,
2006). No modulations were observed in Carontes, IFN-γ, IL-6, IL-1-, IL-21, Netrin-2, and
Rantes by any of the treatments through-out the grow-out. Modulations were detected in
cytokine IL-16, a chemokine known to recruit and activate monocytes and eosinophils (Wigley
and Kaiser, 2003). L. rhamnosus (T4) resulted in higher IL-6 compared to L. reuteri (T3) after
hatch and until day 14 of the grow-out. From day 28 to 49 of grow-out, L. reuteri (T3) reduced
IL-16 levels compared to the MV alone treatment. These results agree with previous research
where IL-16 concentrations were not modulated after a first coccidiosis challenge. However,
after a second challenge, IL-16 levels significantly increased. It seems as if very high levels of
infection are needed to increase IL-16 expression. As previously mentioned, IL-16 has been
characterized as a chemokine. However, it is also considered a pro-inflammatory cytokine, due
to its production of pro-inflammatory cytokines such as IL-6, IL-1 β (Grant et al., 2018). It is
possible that the reduction in IL-16 expression caused by some of the Lactobacillus, limited its
production of pro-inflammatory cytokines, thus resulting in reduced cytokine modulations
through-out the grow-out.
Pentraxin-3 modulations were also detected in the current study. Until recently,
Burkhardt et al., (2019) classified Pentraxin-3 as an important acute phase reaction cytokine, and
a valuable indicator on the severity of the infection. Pentraxin-3 levels seem to increase as the
host is subjected to an intense challenge. In the current study, Pentraxin-3 levels were higher for
the L. animalis treatment on day 0, by L. rhamnosus on day 14, and by L. reuteri on day 21, but
no other changes were detected after day 28. The increased Pentraxin-3 expression during the
first weeks of the grow-out seems to be stimulated by the presence of the different probiotic
bacteria administered in ovo. In agreement with the current study, Brisbin et al., (2008)
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determined that the different cytokine modulations obtained by each probiotic species are
determined by the probiotic’s structural component. The DNA and the peptidoglycan cell
envelope of each probiotic bacterium seem to elicit different immune responses (Brisbin et al.,
2008). Further research is needed to elucidate the varying modulations obtained in Pentraxin-3
levels and their implications in early broiler immunity. The overall modulations obtained in IL12p40, IL-16, and Pentraxin with the early administration of Lactobacillus could stimulate an
early maturation of the immune system, which may be enhanced through the combination of in
ovo and in feed application of probiotics.
Bursa weight and bursa follicle area
The bursa is the central lymphoid structure and an important component of the Gut
Associated Lymphoid Tissue. The bursa is known for the generation of b-cells and their further
maturation and differentiation within its follicular environment (Lillehoj and Trout, 1996). Bcells produce circulating antibodies with the ability to capture soluble antigens at high specificity
(Takahashi, 1967). As each differentiated b-cell binds upon an antigen, cell division occurs, and
more antibodies are produced with the same specificity for the antigen (Lilleloj and Trout, 1996).
In 1986, Glick et al., established that b-cell production, maturation, and overall functioning is
relative to the bursa follicle area available (Glick, 1986).
In the current study, the overall bursa follicle area (BFA) increased through-out the days
of the grow-out, as expected. However, by day 21, seven days after the coccidiosis challenge,
chicks from T2 and T4 had higher BFA compared to the other treatments. By day 28 and 42 of
the grow-out, differences seen on day 21 were lost. However, T3 had an increase in BFA that
was carried through day 42. All Lactobacillus treatments seem to influence the BFA at different
points of the grow-out. However, T3 elicited more prominent changes, which could result in
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better b-cell and antibody production as a response to an antigen. This implicates that
Lactobacillus can stimulate the development of the bursa, thus enhancing its antibody-producing
capabilities.
The bursa weight has also been correlated the immune competence of the bird (Kabir et
al., 2004; Slawinska et al., 2014). It was previously determined that a higher bursa weight can
lead to higher antibody production. However, in the current study, no differences were detected
bursa weight according to any of the treatments evaluated. Similarly, Beck et al., (2019) showed
no differences in spleen or bursa weight by the in ovo inoculation of L. animalis alone. However,
the bursa weight increased with the synergist effects of L. animalis combined with E. faecium.
Perhaps the combine effects of multiple Lactobacillus strains would be more advantageous
compared to a single Lactobacillus strain.
Conclusion
The results of this study demonstrate that L. animalis, L. reuteri, and L. rhamnosus can be
individually inoculated in combination with Marek’s vaccine into fertile broiler eggs without
impacting hatchability and growth performance. The use of industrial Inovoject technology for
the delivery of probiotics has reduced previous negative effects obtained through manual in ovo
inoculation. A single dose of each Lactobacillus strain at approximately 106 cfu per egg resulted
in different modulations in the immune parameters. White blood cell counts were altered after
the inoculation of Lactobacillus, meaning that the first line of immune defense can be activated
earlier with the use of probiotics. Several cytokines, which signal the activation of an immune
response, were modulated throughout the grow-out. It was also observed that each Lactobacillus
increased bursa follicle area at different time points after 3 weeks of hatch. An increased bursa
follicle area could lead to higher antibody production in defense against antigens. The immune
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modulations observed did not alleviate lesion presence due to a coccidiosis challenge in this
study. However, bird performance was not affected by these modulations or by the coccidiosis
challenge. These results indicate that the different Lactobacillus utilized in this study could be
evaluated at higher doses, or combining them as a multi-strain probiotic, to enhance their
abilities to modulate the immune system. A reinforcing dose of Lactobacillus in a feeding stage
could also be evaluated to boost immune modulations further and obtain better levels of
protection against infections.
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Tables
Table 5.1

Effect of in ovo inoculated L. animalis, L. reuteri, and L. rhamnosus on hatch
parameters compared to Marek’s vaccine alone (MV alone).

Hatch parameter

MV
alone
(T1)

MV+ L.
animalis
(T2)

MV+
L.
reuteri
(T3)

MV+ L.
rhamnosus
(T4)

P-value

SEM

Hatch of transfer
Mid dead embryos
Late dead embryos
Pipped embryos
Contaminated embryos
Cull embryos
Avg. chick weight (g)

94.4
0.18
4.54
0.65
0
0.22
42.6

95.3
0.18
4.26
0.62
0
0
41.8

94.4
0.18
4.35
0.91
0
0
42.1

93.7
0
5.46
1.01
0
0
43.7

0.56
0.78
0.58
0.75
0.44
0.08

1.03
0.16
0.81
0.34
0.093
0.24

Avg. egg flat weight1(g)
1807
1814
1813
1821
0.33
5.21
1
Avg. egg flat weight represent the weight of each flat of eggs before set in the incubator. N=18,
where each replicate unit in the treatment was a flat (30 eggs/flat: 540 eggs/treatment).
Differences are considered significant at P ≤ 0.05.
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Table 5.2

Effect of in ovo inoculation of L. animalis, L. reuteri, and L. rhamnosus compared to Marek’s vaccine alone (MV
alone), on live performance parameter during a 42 day grow-out

MV
MV+
MV+
MV+
alone
L. animalis
L. reuteri
L. rhamnosus
P-value
SEM
(T1)
(T2)
(T3)
(T4)
Weight gain (kg)
0.360
0.375
0.365
0.367
0.625
0.0081
d 0-14
Feed intake (kg)
0.44
0.46
0.45
0.46
0.47
0.010
FCR
1.23
1.23
1.27
1.26
0.86
0.038
Weight gain (kg)
0.88
0.89
0.90
0.90
0.86
0.014
d 14-28 Feed intake (kg)
1.24
1.26
1.26
1.24
0.78
0.021
FCR
1.53
1.55
1.53
1.50
0.32
0.017
Weight gain (kg)
1.29
1.28
1.33
1.35
0.46
0.034
d 28-42 Feed intake (kg)
2.08
2.07
2.21
2.17
0.09
0.046
FCR
1.61
1.31
1.66
1.62
0.66
0.034
Weight gain (kg)
2.53
2.54
2.59
2.61
0.51
0.045
d 0-42
Feed intake (kg)
3.26
3.28
3.39
3.34
0.44
0.059
FCR
1.72
1.71
1.73
1.71
0.80
0.020
Differences are considered significant at P ≤ 0.05. N=10, where each replicate in the treatment is represented by each pen. (10
pens/treatment; 18 birds/ pen; 180 birds/treatment)
d of grow Performance
out
parameter
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Table 5.3

Treatment effects on the in ovo inoculation of different Lactobacillus strains on egg yolk, spleen, and bursa weight.

Tissue weight

MV alone
(T1)

MV+ L.
animalis
(T2)

MV+ L.
reuteri
(T3)

MV+ L.
rhamnosus
(T4)

P-value

SEM

Yolk weight (g)
0.588
0.575
0.579
0.613
0.921
2.147
*
Spleen weight (g)
0.100
0.095
0.102
0.090
0.105
0.003
*
Bursa weight (g)
0.518
0.193
0.197
0.212
0.408
0.159
Differences are considered significant at P ≤ 0.05. N=10, where each replicate in the treatment is represented by tissues collected from
one bird from each pen (10 pens/treatment; 18 birds/ pen; 180 birds/treatment).
*
Spleen and bursa weight relative to body weight.

Table 5.4

Percentage lesion score present on each segment of the small intestine, due to a coccidiosis challenge on d 14 of the
grow-out.
Intestinal
segment

MV alone
(T1)

MV+ L.
animalis
(T2)

MV+ L.
reuteri
(T3)

MV+ L.
rhamnosus
(T4)

P-value

SEM

Duodenum (%)
80
85
90
84.2
0.86
7.94
Jejunum (%)
85
100
85
94.7
0.55
7.5
Ileum (%)
45
55
30
47.3
0.82
9.84
Ceca (%)
15
10
50
5.26
0.73
9.38
Differences are considered significant at P ≤ 0.05. N=10, where each replicate in the treatment is represented by intestinal tissues of
one bird from each pen (10 pens/treatment; 18 birds/ pen; 180 birds/treatment).
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Treatment by day interactions for Bursa of Fabricius follicle area of chickens during a 49 day grow-out.

The treatments are represented as follows: The Marek’s vaccine alone (MV alone) treatment (T1) is represented by a dark grey bar.
The MV+L. animalis treatment (T2) is represented by a downward diagonal bar. The MV+ L. reuteri treatment (T3) is represented by
a light grey bar. The MV+ L. rhamnosus treatment (T4) is represented by the dotted bar. On the x-axis represents the sampling days in
the 42 d grow-out. The y-axis represents the follicle area in µm2. The p-value= <0.001, N=10 pens/ treatment (1 chick from each pen
was sampled each d of the grow-out), and the SEM= 1.33, represented in the error bars. Different alphabetical superscript above each
bar (a-i) indicates differences among treatments.
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Treatment by day interactions detected for heterophil-lymphocyte ratios in chicken blood collected during a 49 day
grow-out

The treatments are represented as follows: The Marek’s vaccine alone (MV alone) treatment (T1) is represented by a dark grey bar.
The MV+L. animalis treatment (T2) is represented by a downward diagonal bar. The MV+ L. reuteri treatment (T3) is represented by
a light grey bar. The MV+ L. rhamnosus treatment (T4) is represented by the dotted bar. On the x-axis represents the sampling days in
the 42 d grow-out. The y-axis represents the follicle area in µm2. The p-value=0.0138, N=10 pens/ treatment (1 chick from each pen
was sampled each d of the grow-out), and the SEM= 0.1448, represented in the error bars. Different alphabetical superscript above
each bar (a-d) indicates differences among treatments.
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Treatment by day interactions detected for the cytokine IL-16 recovered from chicken blood collected during a 49 day
grow-out.

The treatments are represented as follows: The Marek’s vaccine alone (MV alone) treatment (T1) is represented by a dark grey bar.
The MV+L. animalis treatment (T2) is represented by a downward diagonal bar. The MV+ L. reuteri treatment (T3) is represented by
a light grey bar. The MV+ L. rhamnosus treatment (T4) is represented by the dotted bar. On the x-axis represents the sampling days in
the 42 d grow-out. The y-axis represents the follicle area in µm2. The p-value=0.0354, N=10 pens/ treatment (1 chick from each pen
was sampled each d of the grow-out), and the SEM= 66.302, represented in the error bars. Different alphabetical superscript above
each bar (a-f) indicates differences among treatments.
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Treatment by day interactions detected for the cytokine Pentraxin3 recovered from chicken blood collected during a 49
day grow-out.

The treatments are represented as follows: The Marek’s vaccine alone (MV alone) treatment (T1) is represented by a dark grey bar.
The MV+L. animalis treatment (T2) is represented by a downward diagonal bar. The MV+ L. reuteri treatment (T3) is represented by
a light grey bar. The MV+ L. rhamnosus treatment (T4) is represented by the dotted bar. On the x-axis represents the sampling days in
the 42 d grow-out. The y-axis represents the follicle area in µm2. The p-value=0.0159, N=10 pens/ treatment (1 chick from each pen
was sampled each d of the grow-out), and the SEM= 136.49, represented in the error bars. Different alphabetical superscript above
each bar (a-d) indicates differences among treatments.

152

60

a
ab

50
pg/ mL

40
30

bc
c

c c

c

c c c

c

c

c

c

c c

c

c

c c

20
10
0
D0
MV alone (T1)

Figure 5.5

D 14
MV+L. animalis (T2)

D 21

D 28

MV+L. reuteri (T3)

D 42
MV+L. rhamnosus (T4)

A trend was detected from the in ovo inoculation of different Lactobacillus strains and a MV alone control on the
cytokine IL-12p40 recovered from chicken blood collected during a 49 day grow-out.

The treatments are represented as follows: The Marek’s vaccine alone (MV alone) treatment (T1) is represented by a dark grey bar.
The MV+L. animalis treatment (T2) is represented by a downward diagonal bar. The MV+ L. reuteri treatment (T3) is represented by
a light grey bar. The MV+ L. rhamnosus treatment (T4) is represented by the dotted bar. On the x-axis represents the sampling days in
the 42 d grow-out. The y-axis represents the follicle area in µm2. The p-value=0.0588, N=10 pens/ treatment (1 chick from each pen
was sampled each d of the grow-out), and the SEM= 7.99, represented in the error bars. Different alphabetical superscript above each
bar (a-c) indicates differences among treatments.
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CHAPTER VI
CONCLUSION
The overall objective of this study was to determine if the early administration of
probiotics through an automated in ovo inoculation method, can provide early benefits to the
embryo and the hatchling chick. The automated Inovoject® technology has been used for more
than 30 years to administer vaccines before hatch; however, we suggest its use for the early
administration of probiotics. This objective was developed due to the need to obtain maximum
protection and beneficial effects to hatching broiler chicks, from probiotic bacteria. Although the
supplementation in the feed seems to confer many health benefits and yield improvements,
special protection is needed during the first few weeks after hatch when the hatchling is most
vulnerable to pathogenic infections. Evaluating further ways to utilize commonly used probiotic
species may optimize their use and get a step closer into finding an efficient alternative to
antibiotics. To achieve the main goal, three main objectives were evaluated within this study.
For the first objective, different concentrations of an Enterococcus faecium based
probiotic were evaluated to determine if there is an optimal dose to improve broiler performance
parameters, as well as intestinal and immune tissue morphology without negatively impacting
hatchability. The probiotic doses were automatically delivered to fertile hatching embryos on day
18 of incubation using Inovoject® technology. The main results of this study demonstrated that
hatchability was not impacted by any of the concentrations of E. faecium evaluated. During the
first week of the grow-out, all chicks that received a probiotic dose in ovo showed higher
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intestinal weights as well as longer intestinal lengths. These morphological changes are believed
to be due to a faster egg yolk consumption seen in probiotic administered chicks. The spleen, one
of the most important immune tissues, exhibited a higher weight for the highest concentration of
E. faecium (107 cfu/50 µL). Higher spleen weight has been previously linked to higher immune
competence of the broiler chick. All of the improvements obtained resulted in improvement in
different performance parameters. The administration of the lowest and highest probiotic doses
(105 cfu/50 µL and 107 cfu/50 µL) resulted in a reduced feed conversion ratio during the first
week after hatch. Body weight was improved in the third week after hatch in chicks administered
the highest concentration of E. faecium. These results indicate that the use of an automated
inoculation system is suitable for probiotic administration and that early benefits can be obtained
in broilers through the early administration of beneficial bacteria.
For the second objective, three B. subtilis serotypes were evaluated to determine their
effect on hatchability, growth performance, and regulations in the intestinal microflora. The
different probiotic serotypes were also delivered using Inovoject® technology on day 18 of
incubation. The main results of this study indicate that some probiotic strains can significantly
reduce hatchability, even if they have been previously shown to be safe for use as a feed
supplement. However, some serotypes did not result in detrimental effects in hatchability and
showed no impacts on growth performance. These serotypes also resulted in different
modulation in coliform and total aerobic bacteria present in the ileum and ceca of the in ovo
inoculated broiler chicks. These results indicate that even though most probiotics are thought to
be beneficial, they need to be thoroughly evaluated before used in any production setting. It is
also apparent that the early administration of some B. subtilis serotypes can begin modulating
bacterial presence even during the first weeks of hatch.
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For the third objective, three Lactobacillus strains were evaluated to determine their
effect in hatchability, growth performance, and broiler immune status. The results indicate that
none of the Lactobacillus strains evaluated affected hatchability or growth performance of the
chick. However, several modulations in different immune parameters were detected even during
the first week after hatch and lasted until the end of the grow-out cycle. The bursa of Fabricius,
an important immune tissue in chickens, developed a higher follicular area due to the in ovo
administration of Lactobacillus, which could allow for a higher production of antibodies against
pathogenic challenges. Cytokines of relevance in poultry, as well as blood cell counts, were
highly modulated during the first weeks after hatch. These changes indicate that the early
delivery of probiotic bacteria stimulates the modulation of different parameters of the immune
system through in ovo injection.
It is evident that the early delivery of probiotic through an automated Inovoject® system
is a feasible method to deliver each probiotic concentration accurately, in a short period, and
without detrimental effects to the broiler embryos. It was also proven that beneficial effects can
be obtained beginning early in the chick’s life, through the in ovo inoculation of different
probiotic bacteria. A single dose of a probiotic bacteria led to the early stimulation of different
immune parameters and modulations in the microflora, which can have great implications for the
defense against pathogenic infections. Obtaining modulations in the first weeks after hatch could
mean that the early administration of probiotics has the potential to fill in the gap in protection
seen from day 7 after hatch, when maternal antibodies are depleted, until day 21 when the
immune system is fully developed. However, additional research is needed to enhance the use of
probiotics further. This could involve determining if different probiotic bacteria have preferred
sites of colonization after administered in ovo. Delivering a combination of probiotics to provide
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a wide range of protection across the entire intestinal tract of the bird could result in additional
beneficial effects. Optimizing the use of probiotics could get the poultry industry closer to
obtaining a suitable alternative to antibiotics. Therefore, this could reduce the presence of
bacteria in chicken products, ultimately reducing the economic losses due to current broiler
diseases and lowering the incidence of human infection due to food-borne pathogens related to
poultry.
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